| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF384 SP3 HNF1B HIF1A ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ZNF628 RBL2 SREBF1 SREBF2 MLXIP ZNF236 RFX3 CREB1 CREBBP MEF2C CREB5 GTF2A1 ZNF773 USF3 NFATC2 NFE2L2 UBP1 NFYA PKNOX1 ZNF620 ZNF281 HCFC1 GABPA | 1.51e-07 | 1459 | 160 | 32 | GO:0000977 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 3.29e-07 | 19 | 160 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.07e-07 | 85 | 160 | 8 | GO:0019199 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF384 SP3 HNF1B TSHZ3 HIF1A ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ZNF628 SREBF1 SREBF2 ADNP2 MLXIP ZNF236 RFX3 CREB1 MEF2C CREB5 ZNF773 USF3 NFATC2 NFE2L2 UBP1 NFYA PKNOX1 ZNF620 ZNF281 GABPA | 7.77e-07 | 1412 | 160 | 30 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF384 SP3 HNF1B HIF1A ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ZNF628 SREBF1 SREBF2 MLXIP ZNF236 RFX3 CREB1 MEF2C CREB5 ZNF773 NFATC2 NFE2L2 UBP1 NFYA PKNOX1 ZNF281 HCFC1 GABPA | 2.03e-06 | 1244 | 160 | 27 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF384 SP3 HNF1B HIF1A ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ZNF628 SREBF1 SREBF2 MLXIP ZNF236 RFX3 CREB1 MEF2C CREB5 ZNF773 NFATC2 NFE2L2 UBP1 NFYA PKNOX1 ZNF281 HCFC1 GABPA | 3.04e-06 | 1271 | 160 | 27 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF384 HIF1A ZNF143 FOXK2 ZNF628 SREBF1 MLXIP CREB1 MEF2C CREB5 BNC1 USF3 NFATC2 NFE2L2 UBP1 NFYA GABPA | 3.14e-06 | 566 | 160 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 5.06e-06 | 15 | 160 | 4 | GO:0005005 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR SP3 TSHZ3 ZNF143 EP400 RBL2 SREBF1 SREBF2 CREBBP MEF2C PHF21A PHC1 WAC TOX4 NFATC2 PKNOX1 NIPBL HCFC1 GABPA | 7.63e-06 | 739 | 160 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | SP3 HNF1B HIF1A SREBF1 RUNX1T1 CREB1 CREBBP MEF2C YEATS2 GTF2A1 NFATC2 NFE2L2 ARID2 NFYA MED12L SPOP TAF4 MNDA HCFC1 | 9.94e-06 | 753 | 160 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF384 HIF1A ZNF143 FOXK2 ZNF628 SREBF1 MLXIP CREB1 MEF2C CREB5 USF3 NFATC2 NFE2L2 UBP1 NFYA GABPA | 1.16e-05 | 560 | 160 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.35e-05 | 65 | 160 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.73e-05 | 7 | 160 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DHX16 ANKRD13B TPR PRPF31 GTF2A1L BLNK MAML1 ATG14 LAMP2 ATG2A RUNX1T1 WNK1 CREBBP YEATS2 KMT2C TSC22D1 BRDT AP1G1 NFATC2 NFE2L2 MED12L LTBP1 GCN1 NIPBL HCFC1 NPAT | 2.86e-05 | 1356 | 160 | 26 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.37e-04 | 140 | 160 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ANKRD13B TPR PRPF31 GTF2A1L BLNK MAML1 ATG14 LAMP2 ATG2A RUNX1T1 WNK1 CREBBP YEATS2 KMT2C TSC22D1 BRDT AP1G1 NFE2L2 MED12L NIPBL HCFC1 NPAT | 1.48e-04 | 1160 | 160 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.84e-04 | 43 | 160 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | protein dimerization activity | TPR HNF1B HIF1A NTRK1 SREBF1 SREBF2 MLXIP CUBN DSCAML1 MEF2C GTF2A1 USF3 TENM4 DST NAE1 XCL2 LRP6 TAF4 MAP3K21 ENG XCL1 | 6.48e-04 | 1205 | 160 | 21 | GO:0046983 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.73e-04 | 303 | 160 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.12e-03 | 145 | 160 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.29e-03 | 326 | 160 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | GTF2A1L MAML1 RUNX1T1 CREBBP YEATS2 KMT2C TSC22D1 BRDT MED12L NIPBL HCFC1 NPAT | 1.95e-03 | 562 | 160 | 12 | GO:0003712 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF384 SP3 HNF1B HIF1A ZNF143 FOXK2 HIVEP1 ZNF148 ING3 PPP1R12A SREBF1 SREBF2 MAML1 MLXIP RFX3 CREB1 CREBBP MEF2C CREB5 MAP3K1 KMT2C GTF2A1 TSC22D1 PRDM10 USF3 NFATC2 NFE2L2 UBP1 ARID2 PKD1 NFYA MED12L PKNOX1 LRP6 TAF4 ENG NIPBL HCFC1 GABPA NPAT | 3.16e-13 | 1390 | 161 | 40 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | HMBOX1 TPR SP3 HNF1B TSHZ3 HIF1A FOXK2 HIVEP1 ZBTB33 ZNF148 SREBF1 SREBF2 RUNX1T1 RFX3 CREB1 CREBBP MEF2C PHF21A PHC1 YEATS2 NFATC2 SPOP ENG XCL1 ZNF281 NIPBL HCFC1 GABPA NPAT | 1.20e-06 | 1399 | 161 | 29 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | HMBOX1 TPR SP3 HNF1B TSHZ3 HIF1A FOXK2 HIVEP1 ZBTB33 ZNF148 SREBF1 SREBF2 RUNX1T1 RFX3 CREB1 CREBBP MEF2C PHF21A PHC1 YEATS2 NFATC2 SPOP ENG XCL1 ZNF281 NIPBL HCFC1 GABPA NPAT | 1.47e-06 | 1413 | 161 | 29 | GO:1902679 |
| GeneOntologyBiologicalProcess | tube development | EPHB2 RC3H2 SP3 HNF1B TSHZ3 HIF1A STAB2 PDGFRB NTRK1 SREBF1 TNRC6C WNK1 CREB1 MEF2C RYR2 OPRPN PTPRJ NFE2L2 UBP1 ARID2 PKD1 PKNOX1 LRP6 ENG NIPBL EPHA4 EPHB1 | 1.15e-05 | 1402 | 161 | 27 | GO:0035295 |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 SP3 HNF1B TSHZ3 HIF1A PDGFRB SLC34A2 TNRC6C CUBN WNK1 CREBBP DSCAML1 MEF2C RYR2 YEATS2 TENM4 SEC24C NFE2L2 ARID2 PKD1 LRP6 ENG ZNF281 NIPBL HCFC1 GABPA NPAT | 1.78e-05 | 1437 | 161 | 27 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 2.31e-05 | 44 | 161 | 5 | GO:1905168 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | HMBOX1 TPR SP3 HNF1B HIF1A FOXK2 HIVEP1 ZBTB33 ZNF148 SREBF1 SREBF2 CREBBP MEF2C PHF21A YEATS2 NFATC2 SPOP ENG ZNF281 NIPBL HCFC1 GABPA | 2.43e-05 | 1053 | 161 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TPR HNF1B ING3 EP400 RBL2 PIWIL1 CREB1 CREBBP EMSY PHF21A PHC1 WAC YEATS2 KMT2C GTF2A1 BRDT ARID2 BICRAL TAF4 NIPBL HCFC1 | 3.46e-05 | 999 | 161 | 21 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 3.84e-05 | 80 | 161 | 6 | GO:0045911 | |
| GeneOntologyBiologicalProcess | external genitalia morphogenesis | 6.06e-05 | 2 | 161 | 2 | GO:0035261 | |
| GeneOntologyBiologicalProcess | mature natural killer cell chemotaxis | 6.06e-05 | 2 | 161 | 2 | GO:0035782 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 6.32e-05 | 54 | 161 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB2 CACNA1A SP3 HNF1B HIF1A STAB2 PDGFRB NTRK1 TNRC6C WNK1 MEF2C RBM20 OPRPN TENM4 CSF3R PTPRJ NFATC2 NFE2L2 UBP1 PKD1 PKNOX1 LRP6 ENG IL4R GABPA EPHB1 | 8.30e-05 | 1483 | 161 | 26 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of immune response | EPHB2 RC3H2 BLNK SREBF1 LAMP2 WNK1 CREBBP HMCES MEF2C MAP3K1 OPRPN PTPRJ AP1G1 NFATC2 IGHE NFE2L2 XCL2 XCL1 MUC4 MNDA IL4R | 1.12e-04 | 1085 | 161 | 21 | GO:0050776 |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin production | 1.14e-04 | 61 | 161 | 5 | GO:0002639 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB2 HIF1A STAB2 PDGFRB NTRK1 MAML1 WNK1 CREB1 MEF2C RBM20 RYR2 OPRPN TENM4 PTPRJ NFATC2 NFE2L2 UBP1 ARID2 PKD1 PKNOX1 LRP6 LTBP1 ENG NIPBL EPHB1 | 1.38e-04 | 1442 | 161 | 25 | GO:0072359 |
| GeneOntologyBiologicalProcess | response to fluid shear stress | 1.55e-04 | 35 | 161 | 4 | GO:0034405 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 1.60e-04 | 14 | 161 | 3 | GO:0071166 | |
| GeneOntologyBiologicalProcess | regulation of B cell chemotaxis | 1.81e-04 | 3 | 161 | 2 | GO:2000537 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell chemotaxis | 1.81e-04 | 3 | 161 | 2 | GO:2000538 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin production in mucosal tissue | 1.81e-04 | 3 | 161 | 2 | GO:2000558 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin production in mucosal tissue | 1.81e-04 | 3 | 161 | 2 | GO:2000557 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPHB2 HNF1B HIF1A STAB2 PDGFRB NTRK1 WNK1 MEF2C RYR2 OPRPN PTPRJ NFE2L2 UBP1 ARID2 PKD1 PKNOX1 LRP6 ENG NIPBL EPHA4 EPHB1 | 1.85e-04 | 1125 | 161 | 21 | GO:0035239 |
| GeneOntologyBiologicalProcess | response to wounding | EPHB2 KRT6A KRT6B HIF1A NTRK1 MUC16 MAP3K1 KIAA0319 BNC1 DST PTPRJ NFE2L2 ENTPD1 ENG EPHA4 | 2.10e-04 | 659 | 161 | 15 | GO:0009611 |
| GeneOntologyBiologicalProcess | positive regulation of T cell chemotaxis | 2.43e-04 | 16 | 161 | 3 | GO:0010820 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | RC3H2 BLNK WNK1 CREBBP MEF2C MAP3K1 OPRPN PTPRJ NFATC2 IGHE MNDA | 2.71e-04 | 393 | 161 | 11 | GO:0002768 |
| GeneOntologyBiologicalProcess | heart development | HIF1A PDGFRB MAML1 WNK1 CREB1 MEF2C RBM20 RYR2 TENM4 PTPRJ ARID2 PKD1 LRP6 LTBP1 ENG NIPBL | 2.95e-04 | 757 | 161 | 16 | GO:0007507 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | TNRC6C CREB1 CREBBP MEF2C MAP3K1 TSC22D1 XCL2 LTBP1 ENG XCL1 | 3.19e-04 | 336 | 161 | 10 | GO:0071560 |
| GeneOntologyBiologicalProcess | positive regulation of immune response | RC3H2 BLNK SREBF1 LAMP2 WNK1 CREBBP HMCES MEF2C OPRPN PTPRJ AP1G1 NFATC2 IGHE XCL2 XCL1 MNDA IL4R | 3.37e-04 | 845 | 161 | 17 | GO:0050778 |
| GeneOntologyBiologicalProcess | B cell activation | 3.58e-04 | 341 | 161 | 10 | GO:0042113 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | TNRC6C CREB1 CREBBP MEF2C MAP3K1 TSC22D1 XCL2 LTBP1 ENG XCL1 | 3.75e-04 | 343 | 161 | 10 | GO:0071559 |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 3.75e-04 | 223 | 161 | 8 | GO:0050851 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 3.85e-04 | 79 | 161 | 5 | GO:0050853 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 4.08e-04 | 80 | 161 | 5 | GO:0003143 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 4.49e-04 | 351 | 161 | 10 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic organ development | EPHB2 SP3 HNF1B HIF1A TNRC6C DSCAML1 MEF2C RYR2 ARID2 PKD1 LRP6 ENG NIPBL | 4.73e-04 | 561 | 161 | 13 | GO:0048568 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | EPHB2 SP3 HNF1B HIF1A TNRC6C WNK1 CREBBP DSCAML1 MEF2C RYR2 TENM4 LRP6 ENG ZNF281 NIPBL | 4.81e-04 | 713 | 161 | 15 | GO:0048598 |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.83e-04 | 20 | 161 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | positive regulation of type 2 immune response | 4.83e-04 | 20 | 161 | 3 | GO:0002830 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 4.84e-04 | 83 | 161 | 5 | GO:0010569 | |
| GeneOntologyBiologicalProcess | wound healing | EPHB2 KRT6A KRT6B HIF1A MUC16 MAP3K1 BNC1 DST PTPRJ NFE2L2 ENTPD1 ENG | 5.08e-04 | 493 | 161 | 12 | GO:0042060 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.31e-04 | 235 | 161 | 8 | GO:0002822 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 5.35e-04 | 359 | 161 | 10 | GO:0002429 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 5.76e-04 | 49 | 161 | 4 | GO:1904646 | |
| GeneOntologyBiologicalProcess | vasculature development | EPHB2 HIF1A STAB2 PDGFRB NTRK1 WNK1 MEF2C OPRPN PTPRJ NFATC2 NFE2L2 UBP1 ARID2 PKD1 PKNOX1 LTBP1 ENG EPHB1 | 5.80e-04 | 969 | 161 | 18 | GO:0001944 |
| GeneOntologyBiologicalProcess | positive regulation of thymocyte migration | 5.96e-04 | 5 | 161 | 2 | GO:2000412 | |
| GeneOntologyBiologicalProcess | hindbrain tangential cell migration | 5.96e-04 | 5 | 161 | 2 | GO:0021934 | |
| GeneOntologyBiologicalProcess | immunoglobulin production in mucosal tissue | 5.96e-04 | 5 | 161 | 2 | GO:0002426 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | EPHB2 RC3H2 SP3 NTRK1 BLNK HMCES MEF2C PTPRJ AP1G1 NFATC2 IGHE ARID2 XCL2 PKNOX1 XCL1 MNDA IL4R EPHB1 | 6.30e-04 | 976 | 161 | 18 | GO:0046649 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte chemotaxis | 6.45e-04 | 22 | 161 | 3 | GO:0140131 | |
| GeneOntologyBiologicalProcess | chromatin organization | TPR ING3 EP400 RBL2 PIWIL1 CREBBP EMSY PHF21A PHC1 WAC YEATS2 KMT2C BRDT ARID2 BICRAL NIPBL HCFC1 | 6.55e-04 | 896 | 161 | 17 | GO:0006325 |
| GeneOntologyCellularComponent | chromatin | HMBOX1 SP3 HNF1B TSHZ3 HIF1A ZNF143 FOXK2 ZBTB33 ING3 EP400 RBL2 SREBF1 SREBF2 ADNP2 MLXIP RFX3 CREB1 CREBBP MEF2C CREB5 PHC1 YEATS2 RAD51AP1 PRDM10 TOX4 BRDT NFATC2 NFE2L2 UBP1 ARID2 NFYA PKNOX1 BICRAL TAF4 NIPBL HCFC1 GABPA | 9.94e-11 | 1480 | 160 | 37 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | KPNA4 DHX16 TPR PRPF31 HIF1A ZNF143 ING3 GTF2A1L EP400 PTBP2 MLXIP CREB1 CREBBP PHF21A PHC1 WAC KMT2C GTF2A1 SMG7 NFATC2 NFE2L2 ARID2 NXT1 NFYA MED12L BICRAL TAF4 SRRM2 NIPBL HCFC1 AQR KPNA3 | 1.37e-08 | 1377 | 160 | 32 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | SP3 HNF1B HIF1A ZNF143 GTF2A1L RBL2 MLXIP RFX3 CREB1 CREBBP GTF2A1 PRDM10 NFATC2 NFE2L2 ARID2 NFYA PKNOX1 TAF4 | 7.65e-07 | 596 | 160 | 18 | GO:0005667 |
| GeneOntologyCellularComponent | calcium channel complex | 2.04e-05 | 73 | 160 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | HIF1A GTF2A1L MLXIP CREB1 CREBBP GTF2A1 NFATC2 NFE2L2 NFYA TAF4 | 4.84e-05 | 272 | 160 | 10 | GO:0090575 |
| GeneOntologyCellularComponent | nuclear body | HMBOX1 PRPF31 SP3 HIF1A HIVEP1 EP400 MAML1 CREBBP MEF2C PHC1 WAC PTPRH NXT1 ZNF638 SPOP SRRM2 ENG MNDA NPAT | 6.40e-05 | 903 | 160 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 8.55e-05 | 94 | 160 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | nuclear speck | PRPF31 HIF1A EP400 MAML1 MEF2C WAC PTPRH NXT1 ZNF638 SPOP SRRM2 MNDA | 1.25e-04 | 431 | 160 | 12 | GO:0016607 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.50e-04 | 104 | 160 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.94e-04 | 109 | 160 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | microvillus membrane | 1.99e-04 | 38 | 160 | 4 | GO:0031528 | |
| GeneOntologyCellularComponent | early endosome | MON2 ANKRD13B NTRK1 KIAA0319 AP1G1 NAE1 LRP6 GATD1 KIFC1 EPHA4 EPHA8 EPHB1 | 3.42e-04 | 481 | 160 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.86e-04 | 45 | 160 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.20e-04 | 46 | 160 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | transcription factor TFIIA complex | 5.73e-04 | 5 | 160 | 2 | GO:0005672 | |
| GeneOntologyCellularComponent | endosome | MON2 ANKRD13B CCDC22 SLC31A2 NTRK1 LAMP2 CUBN PLEKHM1 TUBG1 KIAA0319 AP1G1 NAE1 LRP6 GATD1 RNF128 DOP1A KIFC1 EPHA4 EPHA8 EPHB1 | 6.14e-04 | 1167 | 160 | 20 | GO:0005768 |
| GeneOntologyCellularComponent | platelet dense granule membrane | 8.56e-04 | 6 | 160 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 1.19e-03 | 7 | 160 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.25e-03 | 28 | 160 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | early endosome membrane | 1.26e-03 | 212 | 160 | 7 | GO:0031901 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.85e-03 | 32 | 160 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | MLL1 complex | 1.85e-03 | 32 | 160 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.85e-03 | 32 | 160 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 2.03e-03 | 33 | 160 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | cell surface | EPHB2 RC3H2 STAB2 PDGFRB NTRK1 MUC16 CUBN DSCAML1 OPRPN CSF3R PTPRJ ENTPD1 PKD1 LRP6 ENG IL4R IGSF3 EPHA4 | 2.16e-03 | 1111 | 160 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 STAB2 SLC31A2 NTRK1 SREBF1 SREBF2 LAMP2 CUBN PLEKHM1 ITPR1 KIAA0319 SEC24C CSF3R PTPRJ AP1G1 PKD1 LRP6 EPHA4 EPHA8 EPHB1 | 2.40e-03 | 1307 | 160 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 2.52e-03 | 10 | 160 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.63e-03 | 75 | 160 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | vesicle membrane | MON2 STAB2 SLC31A2 NTRK1 SREBF1 SREBF2 LAMP2 CUBN PLEKHM1 ITPR1 KIAA0319 SEC24C CSF3R PTPRJ AP1G1 PKD1 LRP6 EPHA4 EPHA8 EPHB1 | 2.80e-03 | 1325 | 160 | 20 | GO:0012506 |
| HumanPheno | Angular cheilitis | 1.33e-05 | 12 | 68 | 4 | HP:0030318 | |
| MousePheno | abnormal myocardium layer morphology | HIF1A PDGFRB RBL2 LAMP2 WNK1 CREBBP MEF2C RBM20 RYR2 PTPRJ UBP1 ARID2 PKD1 ENG NIPBL HCFC1 | 3.55e-06 | 414 | 139 | 16 | MP:0005329 |
| MousePheno | incomplete somite formation | 4.49e-06 | 44 | 139 | 6 | MP:0001689 | |
| MousePheno | abnormal heart layer morphology | HIF1A PDGFRB RBL2 LAMP2 WNK1 CREBBP MEF2C RBM20 RYR2 PTPRJ UBP1 ARID2 PKD1 ENG NIPBL HCFC1 | 4.53e-06 | 422 | 139 | 16 | MP:0010545 |
| MousePheno | abnormal cardiac muscle tissue morphology | HIF1A PDGFRB RBL2 LAMP2 WNK1 CREBBP MEF2C RBM20 RYR2 PHC1 PTPRJ UBP1 ARID2 PKD1 ENG NIPBL HCFC1 | 7.09e-06 | 489 | 139 | 17 | MP:0010630 |
| MousePheno | abnormal prenatal growth/weight/body size | DPH1 HNF1B HIF1A ZNF148 RBL2 MAML1 ARHGEF12 SLC34A2 CUBN WNK1 CREB1 CREBBP MEF2C RYR2 ITPR1 TOX4 TENM4 DST PAPOLA PTPRJ UBP1 PKD1 XRN1 PKNOX1 LRP6 BICRAL ENG GCN1 MNDA NIPBL HCFC1 GABPA NPAT | 7.46e-06 | 1493 | 139 | 33 | MP:0004196 |
| MousePheno | impaired somite development | 9.01e-06 | 104 | 139 | 8 | MP:0009768 | |
| MousePheno | embryonic lethality during organogenesis | DPH1 HIF1A ZNF148 EP400 RBL2 SREBF1 SLC34A2 CUBN WNK1 RFX3 CREBBP MEF2C RYR2 TENM4 PTPRJ UBP1 ARID2 PKD1 XRN1 BICRAL TAF4 ENG NIPBL | 1.67e-05 | 876 | 139 | 23 | MP:0006207 |
| MousePheno | thin myocardium | 2.14e-05 | 85 | 139 | 7 | MP:0002652 | |
| MousePheno | abnormal embryonic growth/weight/body size | DPH1 HNF1B HIF1A ZNF148 RBL2 ARHGEF12 SLC34A2 CUBN WNK1 CREBBP MEF2C RYR2 ITPR1 TOX4 TENM4 DST PAPOLA PTPRJ UBP1 PKD1 XRN1 PKNOX1 LRP6 BICRAL ENG GCN1 MNDA NIPBL HCFC1 | 2.39e-05 | 1295 | 139 | 29 | MP:0002088 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | HIF1A ZNF148 EP400 RBL2 SLC34A2 CUBN WNK1 CREBBP MEF2C RYR2 TENM4 PTPRJ UBP1 ARID2 XRN1 BICRAL TAF4 ENG NIPBL | 6.35e-05 | 700 | 139 | 19 | MP:0011098 |
| MousePheno | abnormal angiogenesis | TMEM201 HIF1A PDGFRB WNK1 CREBBP MEF2C PTPRJ UBP1 ARID2 PKNOX1 LTBP1 ENG NPAT | 8.59e-05 | 372 | 139 | 13 | MP:0000260 |
| MousePheno | pancreas lipomatosis | 9.82e-05 | 2 | 139 | 2 | MP:0003338 | |
| MousePheno | abnormal heart ventricle morphology | DHX16 HIF1A PDGFRB LAMP2 WNK1 RFX3 CREBBP MEF2C RBM20 MAP3K1 RYR2 PHC1 UBP1 ARID2 PKD1 LTBP1 ENG NIPBL HCFC1 NPAT | 1.10e-04 | 793 | 139 | 20 | MP:0005294 |
| MousePheno | abnormal cardiovascular development | TMEM201 HIF1A ZNF148 PDGFRB RBL2 CUBN WNK1 RFX3 CREBBP MEF2C RYR2 PHC1 PTPRJ UBP1 ARID2 PKD1 PKNOX1 LTBP1 ENG NPAT | 1.28e-04 | 802 | 139 | 20 | MP:0002925 |
| MousePheno | prenatal growth retardation | DPH1 HNF1B HIF1A ZNF148 MAML1 ARHGEF12 WNK1 CREBBP MEF2C RYR2 ITPR1 TOX4 TENM4 PTPRJ UBP1 XRN1 PKNOX1 BICRAL ENG GCN1 NPAT | 1.33e-04 | 869 | 139 | 21 | MP:0010865 |
| MousePheno | delayed intramembranous bone ossification | 1.59e-04 | 28 | 139 | 4 | MP:0003420 | |
| MousePheno | abnormal embryo size | DPH1 HNF1B HIF1A ZNF148 RBL2 ARHGEF12 SLC34A2 CUBN CREBBP ITPR1 DST PAPOLA PTPRJ UBP1 PKD1 PKNOX1 LRP6 ENG GCN1 MNDA NIPBL HCFC1 | 1.83e-04 | 956 | 139 | 22 | MP:0001697 |
| MousePheno | decreased angiogenesis | 1.87e-04 | 84 | 139 | 6 | MP:0005602 | |
| MousePheno | embryonic growth retardation | DPH1 HNF1B HIF1A ZNF148 ARHGEF12 WNK1 CREBBP MEF2C RYR2 ITPR1 TOX4 TENM4 PTPRJ UBP1 XRN1 PKNOX1 BICRAL ENG GCN1 | 1.96e-04 | 763 | 139 | 19 | MP:0003984 |
| MousePheno | abnormal muscle morphology | HIF1A PDGFRB RBL2 NTRK1 MAML1 LAMP2 WNK1 CREB1 CREBBP MEF2C RBM20 RYR2 PHC1 DST PTPRJ UBP1 ARID2 PKD1 LTBP1 ENG NIPBL HCFC1 IGSF3 NPAT | 2.20e-04 | 1106 | 139 | 24 | MP:0002108 |
| MousePheno | abnormal prenatal body size | DPH1 HNF1B HIF1A ZNF148 RBL2 ARHGEF12 SLC34A2 CUBN CREB1 CREBBP ITPR1 DST PAPOLA PTPRJ UBP1 PKD1 PKNOX1 LRP6 ENG GCN1 MNDA NIPBL HCFC1 GABPA | 2.51e-04 | 1116 | 139 | 24 | MP:0010866 |
| MousePheno | perinatal lethality | CACNA1A DPH1 SP3 TSHZ3 ZNF148 PDGFRB PTBP2 LAMP2 TNRC6C RUNX1T1 RFX3 CREBBP MEF2C CREB5 PHF21A PHC1 KMT2C GTF2A1 PKD1 PKNOX1 LRP6 LTBP1 SPOP GCN1 | 3.02e-04 | 1130 | 139 | 24 | MP:0002081 |
| MousePheno | abnormal vascular development | TMEM201 HIF1A ZNF148 PDGFRB CUBN WNK1 CREBBP MEF2C PTPRJ UBP1 ARID2 PKNOX1 LTBP1 ENG NPAT | 3.22e-04 | 542 | 139 | 15 | MP:0000259 |
| MousePheno | abnormal vitelline vascular remodeling | 3.44e-04 | 61 | 139 | 5 | MP:0004076 | |
| MousePheno | abnormal artery development | 3.63e-04 | 133 | 139 | 7 | MP:0003410 | |
| MousePheno | abnormal somite development | 3.76e-04 | 222 | 139 | 9 | MP:0001688 | |
| MousePheno | abnormal heart looping | 3.97e-04 | 135 | 139 | 7 | MP:0000269 | |
| MousePheno | abnormal embryo development | DPH1 HNF1B HIF1A ZNF148 EP400 RBL2 ARHGEF12 SLC34A2 CUBN WNK1 RFX3 CREBBP MEF2C TUBG1 RYR2 ITPR1 TOX4 TENM4 PTPRJ UBP1 XRN1 PKNOX1 LRP6 BICRAL ENG GCN1 NPAT | 4.02e-04 | 1370 | 139 | 27 | MP:0001672 |
| Domain | FN3 | EPHB2 DSCAML1 KIAA0319 CSF3R PTPRH PTPRJ HCFC1 IL4R EPHA4 EPHA8 EPHB1 | 5.77e-07 | 185 | 160 | 11 | SM00060 |
| Domain | FN3_dom | EPHB2 DSCAML1 KIAA0319 CSF3R PTPRH PTPRJ HCFC1 IL4R EPHA4 EPHA8 EPHB1 | 1.92e-06 | 209 | 160 | 11 | IPR003961 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.86e-06 | 14 | 160 | 4 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.86e-06 | 14 | 160 | 4 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.86e-06 | 14 | 160 | 4 | IPR001426 | |
| Domain | EphA2_TM | 4.86e-06 | 14 | 160 | 4 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.86e-06 | 14 | 160 | 4 | IPR001090 | |
| Domain | Eph_TM | 4.86e-06 | 14 | 160 | 4 | IPR027936 | |
| Domain | EPH_lbd | 4.86e-06 | 14 | 160 | 4 | SM00615 | |
| Domain | Ephrin_lbd | 4.86e-06 | 14 | 160 | 4 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.86e-06 | 14 | 160 | 4 | IPR016257 | |
| Domain | EPH_LBD | 4.86e-06 | 14 | 160 | 4 | PS51550 | |
| Domain | FN3 | EPHB2 DSCAML1 CSF3R PTPRH PTPRJ HCFC1 IL4R EPHA4 EPHA8 EPHB1 | 8.56e-06 | 199 | 160 | 10 | PS50853 |
| Domain | Tyr_kinase_cat_dom | 1.05e-05 | 88 | 160 | 7 | IPR020635 | |
| Domain | TyrKc | 1.05e-05 | 88 | 160 | 7 | SM00219 | |
| Domain | - | 3.56e-05 | 106 | 160 | 7 | 1.10.150.50 | |
| Domain | Keratin_2_head | 4.82e-05 | 24 | 160 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 4.82e-05 | 24 | 160 | 4 | PF16208 | |
| Domain | Znf_C2H2-like | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 CREB5 BNC1 PRDM10 ZNF773 ZNF532 ARID2 ZNF620 ZNF638 ZNF281 | 5.29e-05 | 796 | 160 | 19 | IPR015880 |
| Domain | Ephrin_rec_like | 5.70e-05 | 25 | 160 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.70e-05 | 25 | 160 | 4 | IPR011641 | |
| Domain | Znf_C2H2 | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 CREB5 BNC1 PRDM10 ZNF773 ZNF532 ARID2 ZNF620 ZNF638 ZNF281 | 6.15e-05 | 805 | 160 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 CREB5 BNC1 PRDM10 ZNF773 ZNF532 ARID2 ZNF620 ZNF638 ZNF281 | 6.46e-05 | 808 | 160 | 19 | SM00355 |
| Domain | SAM/pointed | 6.69e-05 | 117 | 160 | 7 | IPR013761 | |
| Domain | Keratin_II | 6.69e-05 | 26 | 160 | 4 | IPR003054 | |
| Domain | TFIIA_asu_N | 7.29e-05 | 2 | 160 | 2 | IPR013028 | |
| Domain | TFIIA_asu/bsu | 7.29e-05 | 2 | 160 | 2 | IPR004855 | |
| Domain | Chemokine_XCL1/XCL2 | 7.29e-05 | 2 | 160 | 2 | IPR008105 | |
| Domain | TFIIA | 7.29e-05 | 2 | 160 | 2 | SM01371 | |
| Domain | TFIIA | 7.29e-05 | 2 | 160 | 2 | PF03153 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.10.287.100 | |
| Domain | Gamma_tubulin | 7.29e-05 | 2 | 160 | 2 | IPR002454 | |
| Domain | fn3 | 7.88e-05 | 162 | 160 | 8 | PF00041 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 CREB5 BNC1 PRDM10 ZNF773 ZNF532 ARID2 ZNF620 ZNF281 | 1.19e-04 | 775 | 160 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 CREB5 BNC1 PRDM10 ZNF773 ZNF532 ARID2 ZNF620 ZNF281 | 1.23e-04 | 777 | 160 | 18 | PS00028 |
| Domain | Pkinase_Tyr | 1.24e-04 | 129 | 160 | 7 | PF07714 | |
| Domain | PROTEIN_KINASE_TYR | 1.87e-04 | 97 | 160 | 6 | PS00109 | |
| Domain | SAM | 1.87e-04 | 97 | 160 | 6 | IPR001660 | |
| Domain | Tyr_kinase_AS | 1.87e-04 | 97 | 160 | 6 | IPR008266 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.88e-04 | 138 | 160 | 7 | IPR001245 | |
| Domain | - | 2.18e-04 | 3 | 160 | 2 | 2.30.18.10 | |
| Domain | HNF-1_N | 2.18e-04 | 3 | 160 | 2 | PF04814 | |
| Domain | HNF-1_N | 2.18e-04 | 3 | 160 | 2 | IPR006899 | |
| Domain | TFIIA_b-brl | 2.18e-04 | 3 | 160 | 2 | IPR009088 | |
| Domain | SAM_1 | 2.92e-04 | 68 | 160 | 5 | PF00536 | |
| Domain | Ig-like_fold | EPHB2 PDGFRB NTRK1 DSCAML1 KIAA0319 CSF3R PTPRH PTPRJ NFATC2 IGHE HCFC1 IL4R IGSF3 EPHA4 EPHA8 EPHB1 | 3.79e-04 | 706 | 160 | 16 | IPR013783 |
| Domain | TFIIA_a-hlx | 4.33e-04 | 4 | 160 | 2 | IPR009083 | |
| Domain | EGF_2 | 4.76e-04 | 265 | 160 | 9 | PS01186 | |
| Domain | TAFH | 7.17e-04 | 5 | 160 | 2 | SM00549 | |
| Domain | TAFH_NHR1 | 7.17e-04 | 5 | 160 | 2 | IPR003894 | |
| Domain | TAFH | 7.17e-04 | 5 | 160 | 2 | PS51119 | |
| Domain | TAFH | 7.17e-04 | 5 | 160 | 2 | PF07531 | |
| Domain | SAM | 9.58e-04 | 88 | 160 | 5 | SM00454 | |
| Domain | RIH_assoc-dom | 1.07e-03 | 6 | 160 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.07e-03 | 6 | 160 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.07e-03 | 6 | 160 | 2 | PF08454 | |
| Domain | RIH_dom | 1.07e-03 | 6 | 160 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.07e-03 | 6 | 160 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.07e-03 | 6 | 160 | 2 | IPR015925 | |
| Domain | PKD/REJ-like | 1.07e-03 | 6 | 160 | 2 | IPR002859 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 1.25.10.30 | |
| Domain | REJ | 1.07e-03 | 6 | 160 | 2 | PF02010 | |
| Domain | RYDR_ITPR | 1.07e-03 | 6 | 160 | 2 | PF01365 | |
| Domain | SAM_DOMAIN | 1.35e-03 | 95 | 160 | 5 | PS50105 | |
| Domain | Arm_3 | 1.49e-03 | 7 | 160 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 1.49e-03 | 7 | 160 | 2 | IPR024931 | |
| Domain | Znf_MYM | 1.49e-03 | 7 | 160 | 2 | IPR010507 | |
| Domain | IBB | 1.49e-03 | 7 | 160 | 2 | PF01749 | |
| Domain | Arm_3 | 1.49e-03 | 7 | 160 | 2 | IPR032413 | |
| Domain | zf-FCS | 1.49e-03 | 7 | 160 | 2 | PF06467 | |
| Domain | EGF-like_CS | 1.88e-03 | 261 | 160 | 8 | IPR013032 | |
| Domain | VWA_3 | 1.97e-03 | 8 | 160 | 2 | PF13768 | |
| Domain | IBB | 1.97e-03 | 8 | 160 | 2 | PS51214 | |
| Domain | Intermediate_filament_CS | 2.09e-03 | 63 | 160 | 4 | IPR018039 | |
| Domain | - | ZNF384 SP3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ZNF236 CREB5 PRDM10 ZNF773 ZNF532 ZNF620 ZNF281 | 2.15e-03 | 679 | 160 | 14 | 3.30.160.60 |
| Domain | Importin-a_IBB | 2.52e-03 | 9 | 160 | 2 | IPR002652 | |
| Domain | PKD/Chitinase_dom | 2.52e-03 | 9 | 160 | 2 | IPR022409 | |
| Domain | RFX_DNA_binding | 2.52e-03 | 9 | 160 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 2.52e-03 | 9 | 160 | 2 | IPR003150 | |
| Domain | PKD | 2.52e-03 | 9 | 160 | 2 | SM00089 | |
| Domain | RFX_DBD | 2.52e-03 | 9 | 160 | 2 | PS51526 | |
| Domain | zf-C2H2 | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ZNF236 BNC1 PRDM10 ZNF773 ZNF620 ZNF281 | 2.59e-03 | 693 | 160 | 14 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF384 SP3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ZNF236 CREB5 PRDM10 ZNF773 ZNF532 ZNF620 ZNF281 | 2.62e-03 | 694 | 160 | 14 | IPR013087 |
| Domain | ARM-type_fold | 2.64e-03 | 339 | 160 | 9 | IPR016024 | |
| Domain | HLH | 2.68e-03 | 111 | 160 | 5 | PF00010 | |
| Domain | bZIP_1 | 3.04e-03 | 34 | 160 | 3 | PF00170 | |
| Domain | MIR | 3.14e-03 | 10 | 160 | 2 | PF02815 | |
| Domain | MIR_motif | 3.14e-03 | 10 | 160 | 2 | IPR016093 | |
| Domain | MIR | 3.14e-03 | 10 | 160 | 2 | PS50919 | |
| Domain | MIR | 3.14e-03 | 10 | 160 | 2 | SM00472 | |
| Domain | Filament | 3.23e-03 | 71 | 160 | 4 | SM01391 | |
| Domain | HLH | 3.24e-03 | 116 | 160 | 5 | SM00353 | |
| Domain | BHLH | 3.36e-03 | 117 | 160 | 5 | PS50888 | |
| Domain | IF | 3.40e-03 | 72 | 160 | 4 | PS00226 | |
| Domain | bHLH_dom | 3.49e-03 | 118 | 160 | 5 | IPR011598 | |
| Domain | - | 3.57e-03 | 73 | 160 | 4 | 2.60.120.260 | |
| Domain | Filament | 3.57e-03 | 73 | 160 | 4 | PF00038 | |
| Domain | PKD | 3.81e-03 | 11 | 160 | 2 | PS50093 | |
| Domain | PKD_dom | 3.81e-03 | 11 | 160 | 2 | IPR000601 | |
| Domain | - | 3.81e-03 | 11 | 160 | 2 | 2.60.40.670 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | SP3 HIF1A ZNF143 EP400 RBL2 CUBN CREB1 CREBBP MEF2C PHC1 ZNF281 HCFC1 | 1.88e-05 | 301 | 128 | 12 | MM15983 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HMBOX1 ZNF384 RC3H2 SP3 TSHZ3 HIF1A ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 SREBF1 SREBF2 ADNP2 MLXIP ZNF236 RFX3 CREB1 MEF2C CREB5 BNC1 YEATS2 TSC22D1 TOX4 USF3 NFATC2 NFE2L2 UBP1 NFYA PKNOX1 ZNF281 GABPA | 3.01e-19 | 908 | 161 | 32 | 19274049 |
| Pubmed | HMBOX1 HNF1B TSHZ3 ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ING3 EP400 MAML1 TNRC6C CREB1 CREBBP MEF2C RBM20 EMSY PHF21A YEATS2 KMT2C DST SMG7 ARID2 NFYA XRN1 ZNF638 LRP6 SPOP TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 GABPA KIFC1 NPAT | 8.56e-18 | 1429 | 161 | 37 | 35140242 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | KPNA4 HMBOX1 RC3H2 TSHZ3 FOXK2 HIVEP1 ZNF148 ING3 EP400 RBL2 ADNP2 MAML1 CREBBP RBM20 PHF21A YEATS2 KMT2C UBP1 ARID2 BICRAL KPNA3 | 2.57e-16 | 398 | 161 | 21 | 35016035 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DHX16 TPR PRPF31 ZNF143 FOXK2 ZBTB33 ZNF148 ING3 EP400 RBL2 PPP1R12A MAML1 RUNX1T1 RFX3 CREB1 CREBBP MEF2C CREB5 EMSY PHF21A PRDM10 NFATC2 UBP1 NFYA HCFC1 ZMYM4 GABPA | 3.87e-15 | 857 | 161 | 27 | 25609649 |
| Pubmed | HMBOX1 SP3 HIF1A ZNF143 HIVEP1 ZBTB33 ZNF148 ING3 SREBF1 ZNF236 RFX3 PHF21A PHC1 GTF2A1 TSC22D1 ZNF773 TOX4 BRDT NFE2L2 UBP1 ARID2 NFYA PKNOX1 ZNF638 GABPA | 6.71e-14 | 808 | 161 | 25 | 20412781 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DHX16 PRPF31 ZNF384 TSHZ3 FOXK2 HIVEP1 ZNF148 PTBP2 ADNP2 EMSY PHC1 FSIP2 RAD51AP1 ARID2 TAF4 ZNF281 NIPBL HCFC1 ZMYM4 GABPA KIFC1 NPAT | 1.09e-13 | 608 | 161 | 22 | 36089195 |
| Pubmed | KPNA4 TPR HIVEP1 SREBF2 ADNP2 WNK1 CREB1 CREBBP MEF2C KMT2C GTF2A1 TSC22D1 TOX4 USF3 DST ARID2 NFYA BICRAL MAP3K21 GCN1 | 1.46e-13 | 486 | 161 | 20 | 20936779 | |
| Pubmed | PRPF31 ZNF384 ZNF143 FOXK2 HIVEP1 ZNF148 EP400 MAML1 CREB1 CREBBP EMSY TUBG1 PHF21A WAC YEATS2 KMT2C ARID2 NAE1 BICRAL TAF4 SRRM2 ZNF281 MNDA NIPBL HCFC1 ZMYM4 GABPA KIFC1 | 2.31e-13 | 1103 | 161 | 28 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR PRPF31 ZNF384 ZNF143 HIVEP1 ZBTB33 ZNF148 EP400 PTBP2 CREB1 EMSY WAC YEATS2 RAD51AP1 TOX4 ARID2 ZNF638 TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 KIFC1 NPAT KPNA3 | 3.69e-13 | 954 | 161 | 26 | 36373674 |
| Pubmed | EPHB2 KPNA4 MON2 TPR DPH1 SP3 ING3 RBL2 SREBF1 SREBF2 ZNF236 WNK1 CREB1 EMSY WAC KMT2C PRDM10 SMG7 UBP1 ARID2 XRN1 CKAP2L LTBP1 SPOP TAF4 GCN1 NIPBL ZMYM4 KPNA3 | 3.28e-12 | 1327 | 161 | 29 | 32694731 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TSHZ3 FOXK2 HIVEP1 ZNF148 EP400 MAML1 CREBBP EMSY PHF21A KMT2C ARID2 TAF4 ZNF281 NIPBL ZMYM4 GABPA | 9.89e-12 | 351 | 161 | 16 | 38297188 |
| Pubmed | HMBOX1 SP3 HIF1A FOXK2 HIVEP1 ZBTB33 ING3 SREBF1 SREBF2 CREBBP MEF2C PHF21A PHC1 KMT2C GTF2A1 TOX4 ZNF532 NFATC2 PKNOX1 ZNF638 RNF128 | 1.79e-11 | 709 | 161 | 21 | 22988430 | |
| Pubmed | HIVEP1 ZBTB33 ZNF148 EP400 MAML1 CREB1 CREBBP EMSY PHF21A WAC ZNF281 NIPBL HCFC1 KIFC1 | 3.41e-11 | 268 | 161 | 14 | 33640491 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMBOX1 PRPF31 TMEM201 HIF1A FOXK2 ZNF148 ING3 EP400 SREBF1 MLXIP CREB1 EMSY PHF21A WAC YEATS2 KMT2C TOX4 DST NFE2L2 UBP1 ZNF638 TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 | 5.71e-11 | 1294 | 161 | 27 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZNF384 ZBTB33 ZNF148 EP400 PPP1R12A WNK1 EMSY PHF21A WAC YEATS2 GTF2A1 TOX4 DST SMG7 PAPOLA ARID2 XRN1 ZNF638 ZNF281 GCN1 NIPBL HCFC1 | 7.21e-11 | 934 | 161 | 23 | 33916271 |
| Pubmed | TPR CCDC22 ZBTB33 ZNF148 EP400 PPP1R12A CREBBP EMSY YEATS2 KMT2C TOX4 SMG7 ARID2 XRN1 TAF4 GCN1 HCFC1 ZMYM4 | 1.08e-10 | 549 | 161 | 18 | 38280479 | |
| Pubmed | TPR TSHZ3 HIVEP1 ZBTB33 ZNF148 RBM20 PHF21A PHC1 YEATS2 TOX4 DST ZNF532 XRN1 GCN1 ZMYM4 NPAT | 1.31e-10 | 418 | 161 | 16 | 34709266 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF384 HNF1B HIF1A ZBTB33 GTF2A1L RBL2 SREBF1 SREBF2 MAML1 MLXIP RUNX1T1 ZNF236 RFX3 CREB1 CREBBP MEF2C GTF2A1 NFE2L2 UBP1 NFYA PKNOX1 HCFC1 | 1.37e-10 | 877 | 161 | 22 | 20211142 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | KPNA4 HMBOX1 PRPF31 ZNF384 TMEM201 FOXK2 ZBTB33 ZNF148 EP400 CREB1 CREB5 SEC24C NFATC2 UBP1 TAF4 HCFC1 KIFC1 KPNA3 | 2.82e-10 | 583 | 161 | 18 | 29844126 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | ZNF143 ING3 EP400 EMSY PHC1 YEATS2 KMT2C UBP1 TAF4 HCFC1 ZMYM4 | 4.02e-10 | 167 | 161 | 11 | 20362541 |
| Pubmed | FOXK2 ZNF148 ING3 EP400 MAML1 EMSY PHF21A YEATS2 GTF2A1 TOX4 ZNF281 HCFC1 GABPA NPAT | 7.43e-10 | 339 | 161 | 14 | 30415952 | |
| Pubmed | PRPF31 KRT6B FOXK2 CCDC22 ZNF148 EP400 PPP1R12A YEATS2 GTF2A1 DST AP1G1 ARID2 CKAP2L SRRM2 GABPA KIFC1 | 7.67e-10 | 472 | 161 | 16 | 38943005 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PRPF31 ZNF384 FOXK2 ZNF148 EP400 EMSY WAC TOX4 PAPOLA ZNF638 SRRM2 ZNF281 HCFC1 AQR | 8.02e-10 | 341 | 161 | 14 | 32971831 |
| Pubmed | ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. | 2.20e-09 | 5 | 161 | 4 | 12771217 | |
| Pubmed | MON2 TOR1AIP2 ZBTB33 ZNF148 ING3 EP400 PPP1R12A ADNP2 CREBBP TUBG1 PHF21A YEATS2 RAD51AP1 SMG7 BRDT ARID2 XRN1 BICRAL SPOP TAF4 SRRM2 ZNF281 KPNA3 | 2.23e-09 | 1116 | 161 | 23 | 31753913 | |
| Pubmed | KPNA4 PRPF31 SP3 FOXK2 ING3 EP400 PPP1R12A MAML1 ARHGEF12 LAMP2 EMSY KMT2C DST AP1G1 NFATC2 UBP1 ARID2 XRN1 TAF4 ZNF281 NIPBL ZMYM4 AQR GABPA KIFC1 KPNA3 | 6.34e-09 | 1497 | 161 | 26 | 31527615 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | DHX16 TPR ZBTB33 EP400 EMSY WAC GTF2A1 TOX4 PAPOLA ZNF638 ZNF281 HCFC1 | 9.47e-09 | 283 | 161 | 12 | 30585729 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | HMBOX1 ZNF384 SP3 ZBTB33 SREBF1 SREBF2 RFX3 CREB1 MEF2C CREB5 NFATC2 UBP1 PKNOX1 ZNF281 GABPA | 4.13e-08 | 544 | 161 | 15 | 28473536 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | EPHB2 ZNF384 TMEM201 HIF1A ZNF143 ZBTB33 ING3 PDGFRB SREBF1 LAMP2 CREB5 WAC GTF2A1 TSC22D1 ZNF773 ZNF532 SRRM2 ZNF281 HCFC1 ZMYM4 AQR IGSF3 | 4.31e-08 | 1203 | 161 | 22 | 29180619 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 ZNF384 FOXK2 ZNF628 EP400 SREBF1 MAML1 ATG2A TNRC6C MLXIP ZNF236 WNK1 PLEKHM1 TUBG1 KMT2C DST PKD1 GCN1 HCFC1 IL4R IGSF3 | 4.72e-08 | 1105 | 161 | 21 | 35748872 |
| Pubmed | DHX16 RC3H2 ZNF143 SREBF1 SREBF2 RBM20 ITPR1 DST AP1G1 XRN1 SIK2 ZNF638 RNF128 HCFC1 AQR KIFC1 | 6.81e-08 | 650 | 161 | 16 | 38777146 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ZBTB33 ING3 EP400 ADNP2 RUNX1T1 PHC1 YEATS2 PKNOX1 ZNF638 SRRM2 ZNF281 HCFC1 ZMYM4 | 7.14e-08 | 411 | 161 | 13 | 35182466 |
| Pubmed | 7.36e-08 | 116 | 161 | 8 | 30804394 | ||
| Pubmed | ING3 EP400 MAML1 CREBBP EMSY YEATS2 ZNF281 NIPBL HCFC1 ZMYM4 | 9.60e-08 | 222 | 161 | 10 | 37071664 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 24868893 | ||
| Pubmed | The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1. | 9.74e-08 | 3 | 161 | 3 | 38599542 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 29357356 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 15703171 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 7543104 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KPNA4 SP3 TSHZ3 ING3 EP400 ATG2A WNK1 MAP3K1 USF3 ZNF532 NFE2L2 ARID2 KPNA3 | 1.20e-07 | 430 | 161 | 13 | 35044719 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | DHX16 ZNF384 EP400 CREB5 YEATS2 TOX4 SEC24C ZNF281 GCN1 HCFC1 ZMYM4 KPNA3 | 1.20e-07 | 357 | 161 | 12 | 37059091 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TOR1AIP2 TPR HNF1B TMEM201 FOXK2 MAML1 CREBBP RBM20 YEATS2 KMT2C SMG7 XRN1 ZNF638 | 2.41e-07 | 457 | 161 | 13 | 32344865 |
| Pubmed | 2.92e-07 | 94 | 161 | 7 | 16325481 | ||
| Pubmed | KPNA4 RC3H2 ZNF148 EP400 KMT2C ZNF638 ZNF281 MUC4 GCN1 HCFC1 ZMYM4 AQR KPNA3 | 3.23e-07 | 469 | 161 | 13 | 27634302 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 33040080 | ||
| Pubmed | SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. | 3.88e-07 | 4 | 161 | 3 | 8918891 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 33619246 | ||
| Pubmed | ZBP-89 and Sp3 down-regulate while NF-Y up-regulates SOX18 promoter activity in HeLa cells. | 3.88e-07 | 4 | 161 | 3 | 18496767 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HMBOX1 HIF1A FOXK2 PTBP2 PPP1R12A BLNK SREBF2 TNRC6C ZNF236 CREBBP PLEKHM1 YEATS2 KMT2C TSC22D1 USF3 SMG7 PTPRJ ZNF532 ENTPD1 ZNF638 TAF4 ZMYM4 DOP1A | 4.17e-07 | 1489 | 161 | 23 | 28611215 |
| Pubmed | MON2 DHX16 EP400 ARHGEF12 TNRC6C MLXIP KIAA0319 YEATS2 TENM4 SEC24C SRRM2 AQR | 4.88e-07 | 407 | 161 | 12 | 12693553 | |
| Pubmed | ZNF148 ARHGEF12 CREBBP WAC RAD51AP1 KMT2C UBP1 TAF4 ZMYM4 AQR EPHA4 | 5.18e-07 | 335 | 161 | 11 | 15741177 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.34e-07 | 150 | 161 | 8 | 28242625 | |
| Pubmed | KPNA4 DHX16 TPR PRPF31 ING3 EP400 WAC YEATS2 DST PAPOLA CKAP2L SRRM2 AQR | 7.58e-07 | 506 | 161 | 13 | 30890647 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 9.67e-07 | 5 | 161 | 3 | 21559471 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 20301457 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 1.00e-06 | 17 | 161 | 4 | 12217323 | |
| Pubmed | DHX16 TPR KRT6A CREB1 EMSY TUBG1 DST ZNF638 SRRM2 NIPBL GABPA | 1.05e-06 | 360 | 161 | 11 | 33111431 | |
| Pubmed | 1.15e-06 | 225 | 161 | 9 | 12168954 | ||
| Pubmed | 1.15e-06 | 40 | 161 | 5 | 30898150 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZBTB33 ZNF148 EP400 CREBBP HMCES EMSY PHF21A YEATS2 TAF4 ZNF281 HCFC1 ZMYM4 | 1.21e-06 | 444 | 161 | 12 | 34795231 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 TPR PRPF31 ZNF384 KRT6B TMEM201 CCDC22 EP400 ADNP2 CREBBP DST SEC24C AP1G1 XRN1 ZNF638 SRRM2 ZNF281 GCN1 NIPBL AQR KPNA3 | 1.29e-06 | 1353 | 161 | 21 | 29467282 |
| Pubmed | CACNA1A HIVEP1 ZNF148 SLCO6A1 PLEKHM1 KMT2C DST NFE2L2 SRRM2 | 1.54e-06 | 233 | 161 | 9 | 37704626 | |
| Pubmed | 1.62e-06 | 77 | 161 | 6 | 19505873 | ||
| Pubmed | 1.62e-06 | 121 | 161 | 7 | 22412018 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 1.62e-06 | 19 | 161 | 4 | 16799563 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.62e-06 | 19 | 161 | 4 | 12684176 | |
| Pubmed | TOR1AIP2 ZNF143 HIVEP1 MAML1 MUC16 ATG14 CREBBP RYR2 YEATS2 UBP1 ARID2 ZNF281 NIPBL IGSF3 | 1.80e-06 | 638 | 161 | 14 | 31182584 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.81e-06 | 123 | 161 | 7 | 26912792 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 15927180 | ||
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 1.93e-06 | 6 | 161 | 3 | 19182796 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 2.02e-06 | 20 | 161 | 4 | 11256076 | |
| Pubmed | 2.02e-06 | 20 | 161 | 4 | 10207129 | ||
| Pubmed | 2.02e-06 | 20 | 161 | 4 | 9530499 | ||
| Pubmed | 2.02e-06 | 20 | 161 | 4 | 9576626 | ||
| Pubmed | 2.49e-06 | 21 | 161 | 4 | 9267020 | ||
| Pubmed | 2.49e-06 | 21 | 161 | 4 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 2.49e-06 | 21 | 161 | 4 | 10730216 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 2.49e-06 | 21 | 161 | 4 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 2.49e-06 | 21 | 161 | 4 | 20112066 | |
| Pubmed | 2.52e-06 | 83 | 161 | 6 | 11114734 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 2.77e-06 | 321 | 161 | 10 | 32098917 | |
| Pubmed | 3.10e-06 | 86 | 161 | 6 | 37253089 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 23671189 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | KPNA4 ZNF384 ZNF148 EP400 RFX3 TOX4 DST AP1G1 NIPBL HCFC1 ZMYM4 | 3.67e-06 | 410 | 161 | 11 | 26949251 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | RC3H2 FOXK2 HIVEP1 ADNP2 PHC1 YEATS2 KMT2C FBXO10 LYPD3 ZNF281 HCFC1 ZMYM4 | 3.71e-06 | 495 | 161 | 12 | 27705803 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 HIVEP1 EP400 MAML1 WNK1 CREB1 CREBBP RBM20 EMSY YEATS2 SMG7 ARID2 ZMYM4 | 3.94e-06 | 588 | 161 | 13 | 38580884 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.32e-06 | 91 | 161 | 6 | 28558017 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 4.37e-06 | 24 | 161 | 4 | 16446123 | |
| Pubmed | 4.95e-06 | 202 | 161 | 8 | 24639526 | ||
| Pubmed | The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. | 5.36e-06 | 8 | 161 | 3 | 15454081 | |
| Pubmed | Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. | 5.36e-06 | 8 | 161 | 3 | 14988728 | |
| Pubmed | 7.14e-06 | 27 | 161 | 4 | 31308417 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KPNA4 DHX16 TPR PRPF31 TUBG2 PPP1R12A TUBG1 ITPR1 TOX4 ARID2 LYPD3 GCN1 NIPBL HCFC1 ZMYM4 AQR KIFC1 KPNA3 | 7.42e-06 | 1155 | 161 | 18 | 20360068 |
| Pubmed | 7.69e-06 | 284 | 161 | 9 | 29459677 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 10704386 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 11403717 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 33253166 | ||
| Pubmed | 9.60e-06 | 29 | 161 | 4 | 36800290 | ||
| Pubmed | HMBOX1 CCDC22 EP400 PPP1R12A WNK1 CREBBP PHC1 RAD51AP1 DST XRN1 ZNF638 LTBP1 KIFC1 | 1.06e-05 | 645 | 161 | 13 | 25281560 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 1.10e-05 | 107 | 161 | 6 | 20508642 | |
| Interaction | FEV interactions | ZNF143 HIVEP1 ZNF148 EP400 MAML1 CREB1 CREBBP EMSY PHF21A KMT2C ARID2 TAF4 ZNF281 NIPBL ZMYM4 GABPA KIFC1 | 5.06e-13 | 203 | 159 | 17 | int:FEV |
| Interaction | HDAC1 interactions | KPNA4 ANKRD13B TPR SP3 HNF1B TSHZ3 HIF1A FOXK2 HIVEP1 ZBTB33 ZNF148 EP400 RBL2 SREBF1 RUNX1T1 RFX3 CREB1 CREBBP RBM20 EMSY PHF21A YEATS2 TOX4 DST PAPOLA NFATC2 NFE2L2 NFYA XRN1 ZNF638 GCN1 HCFC1 GABPA NPAT KPNA3 | 1.24e-12 | 1108 | 159 | 35 | int:HDAC1 |
| Interaction | NFYC interactions | ZNF143 FOXK2 HIVEP1 EP400 SREBF2 ADNP2 EMSY USF3 DST NFATC2 ARID2 NXT1 NFYA BICRAL TAF4 | 1.06e-11 | 177 | 159 | 15 | int:NFYC |
| Interaction | FHL2 interactions | SP3 HIF1A ZNF143 FOXK2 ING3 EP400 SREBF2 WNK1 RFX3 CREB1 CREBBP EMSY PHF21A YEATS2 PKNOX1 ZNF620 ZNF638 C2CD6 ZMYM4 GABPA | 4.74e-11 | 396 | 159 | 20 | int:FHL2 |
| Interaction | HNF4A interactions | HIF1A FOXK2 HIVEP1 ZNF148 ING3 EP400 SREBF1 SREBF2 CREBBP EMSY YEATS2 KMT2C ARID2 TAF4 ZNF281 NIPBL ZMYM4 | 6.53e-11 | 275 | 159 | 17 | int:HNF4A |
| Interaction | SNRNP40 interactions | DHX16 PRPF31 ZNF384 RC3H2 KRT6B HIVEP1 EP400 PTBP2 ADNP2 HMCES RBM20 EMSY PHF21A WAC YEATS2 PRDM10 ZNF532 ARID2 TAF4 SRRM2 ZNF281 AQR NPAT KPNA3 | 2.08e-10 | 637 | 159 | 24 | int:SNRNP40 |
| Interaction | HNF1B interactions | HMBOX1 HNF1B FOXK2 HIVEP1 ING3 EP400 MAML1 CREB1 CREBBP KMT2C ARID2 ZNF281 NIPBL ZMYM4 | 3.45e-10 | 190 | 159 | 14 | int:HNF1B |
| Interaction | NFIX interactions | ZNF143 FOXK2 HIVEP1 ZNF148 ING3 EP400 CREB1 EMSY KMT2C ARID2 TAF4 ZNF281 NIPBL ZMYM4 GABPA | 3.63e-10 | 227 | 159 | 15 | int:NFIX |
| Interaction | EGR2 interactions | HIVEP1 ZNF148 EP400 MAML1 CREBBP EMSY PHF21A KMT2C ARID2 ZNF281 NIPBL HCFC1 ZMYM4 | 1.03e-09 | 171 | 159 | 13 | int:EGR2 |
| Interaction | KLF8 interactions | FOXK2 HIVEP1 ZNF148 ING3 EP400 CREBBP EMSY PHF21A YEATS2 ARID2 ZNF638 TAF4 ZNF281 NIPBL ZMYM4 GABPA KIFC1 | 1.04e-09 | 329 | 159 | 17 | int:KLF8 |
| Interaction | NUP50 interactions | KPNA4 DHX16 ZNF384 CCDC22 ZNF148 NTRK1 YEATS2 GTF2A1 TSC22D1 ARID2 SPOP TAF4 SRRM2 ENG KIFC1 NPAT KPNA3 | 1.79e-09 | 341 | 159 | 17 | int:NUP50 |
| Interaction | ELF1 interactions | FOXK2 HIVEP1 ZNF148 EP400 EMSY NFE2L2 ARID2 NFYA TAF4 ZMYM4 GABPA | 4.85e-09 | 126 | 159 | 11 | int:ELF1 |
| Interaction | KLF5 interactions | HIVEP1 ZNF148 EP400 SREBF1 MAML1 CREBBP RBM20 KMT2C ARID2 ZNF281 NIPBL HCFC1 ZMYM4 | 5.12e-09 | 195 | 159 | 13 | int:KLF5 |
| Interaction | KLF15 interactions | TSHZ3 HIVEP1 ZNF148 ING3 EP400 MAML1 CREBBP EMSY KMT2C ARID2 ZNF638 TAF4 ZNF281 NIPBL ZMYM4 | 1.04e-08 | 290 | 159 | 15 | int:KLF15 |
| Interaction | TEAD1 interactions | TSHZ3 FOXK2 HIVEP1 ZNF148 RBL2 CREBBP MEF2C KMT2C ARID2 ZNF281 NIPBL KIFC1 | 1.58e-08 | 176 | 159 | 12 | int:TEAD1 |
| Interaction | H3-3A interactions | KPNA4 DHX16 PRPF31 ZNF384 TSHZ3 FOXK2 HIVEP1 ZNF148 ADNP2 CREBBP EMSY RAD51AP1 KMT2C ARID2 TAF4 ZNF281 NIPBL HCFC1 ZMYM4 GABPA KIFC1 NPAT KPNA3 | 2.45e-08 | 749 | 159 | 23 | int:H3-3A |
| Interaction | KLF3 interactions | TSHZ3 FOXK2 HIVEP1 ZNF148 EP400 EMSY PHF21A ARID2 TAF4 ZNF281 NIPBL ZMYM4 GABPA | 3.32e-08 | 228 | 159 | 13 | int:KLF3 |
| Interaction | PAX6 interactions | HMBOX1 HNF1B TSHZ3 FOXK2 HIVEP1 ZNF148 EP400 CREBBP PHF21A KMT2C ARID2 PKNOX1 C2CD6 ZNF281 NIPBL ZMYM4 | 3.50e-08 | 366 | 159 | 16 | int:PAX6 |
| Interaction | CEBPA interactions | PRPF31 ZNF384 HIF1A ZNF143 FOXK2 HIVEP1 ZNF148 EP400 MAML1 CREB1 CREBBP EMSY TUBG1 PHF21A WAC YEATS2 KMT2C ARID2 NAE1 NFYA BICRAL TAF4 SRRM2 ZNF281 MNDA NIPBL HCFC1 ZMYM4 GABPA KIFC1 | 3.66e-08 | 1245 | 159 | 30 | int:CEBPA |
| Interaction | TERF2IP interactions | KPNA4 DHX16 FOXK2 HIVEP1 ZNF148 EP400 CREBBP EMSY PHC1 YEATS2 ZNF638 TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 KIFC1 NPAT | 7.79e-08 | 552 | 159 | 19 | int:TERF2IP |
| Interaction | SMC5 interactions | TPR PRPF31 ZNF384 ZNF143 HIVEP1 ZBTB33 ZNF148 EP400 PTBP2 CREB1 EMSY WAC YEATS2 RAD51AP1 TOX4 ARID2 ZNF638 TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 KIFC1 NPAT KPNA3 | 7.81e-08 | 1000 | 159 | 26 | int:SMC5 |
| Interaction | CIC interactions | KPNA4 HMBOX1 PRPF31 ZNF384 HNF1B TMEM201 FOXK2 ZBTB33 ZNF148 EP400 NTRK1 CREB1 CREB5 PHF21A SEC24C NFATC2 UBP1 TAF4 HCFC1 KIFC1 KPNA3 | 8.08e-08 | 673 | 159 | 21 | int:CIC |
| Interaction | TFCP2L1 interactions | 8.91e-08 | 99 | 159 | 9 | int:TFCP2L1 | |
| Interaction | CREB1 interactions | HNF1B HIF1A HIVEP1 SREBF2 RFX3 CREB1 CREBBP GTF2A1 TOX4 AP1G1 NFATC2 NFYA TAF4 | 1.17e-07 | 254 | 159 | 13 | int:CREB1 |
| Interaction | YY1 interactions | SP3 HNF1B HIVEP1 EP400 SREBF1 CREB1 CREBBP EMSY YEATS2 TOX4 NFE2L2 ARID2 ZNF638 TAF4 HCFC1 ZMYM4 GABPA | 1.20e-07 | 454 | 159 | 17 | int:YY1 |
| Interaction | SP7 interactions | HNF1B TSHZ3 HIVEP1 ZNF148 EP400 MAML1 CREBBP RBM20 KMT2C ARID2 ZNF638 ZNF281 NIPBL GABPA | 1.39e-07 | 304 | 159 | 14 | int:SP7 |
| Interaction | BRCA1 interactions | HMBOX1 TPR HIF1A HIVEP1 ZNF148 RBL2 TNRC6C CUBN RUNX1T1 CREB1 CREBBP CREB5 EMSY TUBG1 MAP3K1 ITIH5 ITPR1 DST SMG7 SEC24C NFE2L2 NFYA C2CD6 MAP3K21 GCN1 NIPBL HCFC1 KIFC1 KPNA3 | 1.42e-07 | 1249 | 159 | 29 | int:BRCA1 |
| Interaction | CDK8 interactions | HIF1A HIVEP1 PPP1R12A SREBF1 MAML1 CREBBP YEATS2 MED12L ZNF281 NIPBL ZMYM4 AQR | 2.04e-07 | 222 | 159 | 12 | int:CDK8 |
| Interaction | AR interactions | TPR DPH1 HIF1A HIVEP1 ZBTB33 ZNF148 EP400 BLNK SREBF1 MAML1 CREB1 CREBBP EMSY PHF21A WAC KMT2C ARID2 MED12L SPOP ZNF281 GCN1 NIPBL HCFC1 ZMYM4 KIFC1 | 2.58e-07 | 992 | 159 | 25 | int:AR |
| Interaction | TLE3 interactions | HNF1B TSHZ3 HIVEP1 NTRK1 MAML1 CREBBP RBM20 EMSY WAC SMG7 ARID2 TAF4 SRRM2 ZNF281 NIPBL | 3.11e-07 | 376 | 159 | 15 | int:TLE3 |
| Interaction | RCOR1 interactions | TPR HNF1B TSHZ3 FOXK2 HIVEP1 ZBTB33 PPP1R12A RBM20 PHF21A YEATS2 TOX4 DST NFATC2 XRN1 GCN1 ZMYM4 NPAT | 3.95e-07 | 494 | 159 | 17 | int:RCOR1 |
| Interaction | H3C3 interactions | PRPF31 ZNF384 TSHZ3 FOXK2 HIVEP1 ZNF148 PTBP2 ADNP2 PHC1 FSIP2 ARID2 ZNF281 NIPBL ZMYM4 GABPA KIFC1 NPAT | 4.07e-07 | 495 | 159 | 17 | int:H3C3 |
| Interaction | ELF2 interactions | EPHB2 ZNF143 HIVEP1 ZNF148 EP400 MEF2C EMSY ZNF281 GABPA EPHB1 | 4.60e-07 | 156 | 159 | 10 | int:ELF2 |
| Interaction | NUP43 interactions | HIVEP1 EP400 PPP1R12A EMSY PHF21A RYR2 FSIP2 YEATS2 DST ZNF532 ARID2 TAF4 SRRM2 ZNF281 NIPBL HCFC1 ZMYM4 GABPA NPAT | 5.23e-07 | 625 | 159 | 19 | int:NUP43 |
| Interaction | RBBP4 interactions | KPNA4 SP3 TSHZ3 FOXK2 RBL2 NTRK1 LAMP2 CREB1 CREBBP EMSY ZNF532 NFATC2 SPOP SRRM2 HCFC1 AQR NPAT KPNA3 | 6.66e-07 | 573 | 159 | 18 | int:RBBP4 |
| Interaction | NAA40 interactions | DHX16 TPR ZNF384 ZBTB33 ZNF148 EP400 PPP1R12A WNK1 EMSY PHF21A WAC YEATS2 GTF2A1 TOX4 DST SMG7 PAPOLA ARID2 XRN1 ZNF638 ZNF281 GCN1 NIPBL HCFC1 | 7.43e-07 | 978 | 159 | 24 | int:NAA40 |
| Interaction | SMARCA4 interactions | HIF1A EP400 RBL2 NTRK1 PPP1R12A SREBF1 MAML1 CREB1 CREBBP BRDT NFATC2 NFE2L2 ARID2 BICRAL SRRM2 KPNA3 | 8.15e-07 | 462 | 159 | 16 | int:SMARCA4 |
| Interaction | POU5F1 interactions | TPR ZNF143 EP400 PTBP2 MUC16 CUBN CREB1 EMSY TUBG1 PHC1 YEATS2 TOX4 BRDT UBP1 ZNF281 GCN1 HCFC1 KPNA3 | 8.75e-07 | 584 | 159 | 18 | int:POU5F1 |
| Interaction | JUN interactions | HIF1A PTBP2 CREB1 CREBBP CREB5 PHF21A MAP3K1 KMT2C AP1G1 NFATC2 NFE2L2 NAE1 NFYA GATD1 TAF4 HCFC1 | 1.02e-06 | 470 | 159 | 16 | int:JUN |
| Interaction | FOS interactions | EPHB2 HIF1A HIVEP1 EP400 RBL2 PPP1R12A CREB1 CREBBP CREB5 KMT2C NFATC2 NFE2L2 ARID2 | 1.22e-06 | 312 | 159 | 13 | int:FOS |
| Interaction | CREBBP interactions | SP3 HNF1B HIF1A HIVEP1 RBL2 SREBF1 SREBF2 MAML1 LAMP2 CREB1 CREBBP SMG7 PAPOLA NFATC2 NFE2L2 NFYA GABPA NPAT | 1.26e-06 | 599 | 159 | 18 | int:CREBBP |
| Interaction | HDAC2 interactions | KPNA4 KRT6A SP3 KRT6B HIF1A FOXK2 EP400 NTRK1 PPP1R12A RUNX1T1 WNK1 RFX3 CREB1 CREBBP EMSY PHF21A PHC1 NFE2L2 LTBP1 SRRM2 HCFC1 KPNA3 | 1.26e-06 | 865 | 159 | 22 | int:HDAC2 |
| Interaction | KDM1A interactions | TPR KRT6A KRT6B TSHZ3 HIVEP1 ZBTB33 ZNF148 EP400 NTRK1 PPP1R12A RBM20 PHF21A PHC1 YEATS2 DST SMG7 ZNF532 NFATC2 NFE2L2 XRN1 GCN1 ZMYM4 NPAT | 1.39e-06 | 941 | 159 | 23 | int:KDM1A |
| Interaction | KLF16 interactions | ZNF143 FOXK2 HIVEP1 ZBTB33 ZNF148 ING3 EP400 EMSY ARID2 TAF4 ENG ZNF281 NIPBL GABPA NPAT | 1.45e-06 | 425 | 159 | 15 | int:KLF16 |
| Interaction | RNF4 interactions | EPHB2 KPNA4 ZNF384 TMEM201 HIF1A ZNF143 ZBTB33 ING3 PDGFRB SREBF1 LAMP2 RUNX1T1 CREB1 CREB5 PHC1 WAC YEATS2 GTF2A1 TSC22D1 ZNF773 ZNF532 NFE2L2 SRRM2 ZNF281 HCFC1 ZMYM4 AQR IGSF3 KPNA3 | 1.76e-06 | 1412 | 159 | 29 | int:RNF4 |
| Interaction | FBXO38 interactions | 2.29e-06 | 145 | 159 | 9 | int:FBXO38 | |
| Interaction | SLX4 interactions | DHX16 ZNF384 ING3 EP400 MAML1 CREBBP CREB5 EMSY YEATS2 TOX4 SEC24C ZNF281 GCN1 NIPBL HCFC1 ZMYM4 KPNA3 | 2.93e-06 | 572 | 159 | 17 | int:SLX4 |
| Interaction | CBX3 interactions | DHX16 ZNF148 EP400 PPP1R12A ADNP2 WAC YEATS2 RAD51AP1 PRDM10 NFATC2 ARID2 TAF4 SRRM2 ZNF281 NIPBL ZMYM4 GABPA KIFC1 | 3.63e-06 | 646 | 159 | 18 | int:CBX3 |
| Interaction | ELF4 interactions | 3.64e-06 | 115 | 159 | 8 | int:ELF4 | |
| Interaction | SOX7 interactions | 3.86e-06 | 82 | 159 | 7 | int:SOX7 | |
| Interaction | TBXT interactions | 3.89e-06 | 116 | 159 | 8 | int:TBXT | |
| Interaction | XRCC6 interactions | DHX16 TPR RC3H2 HNF1B HIF1A ZBTB33 EP400 NTRK1 CREBBP EMSY WAC GTF2A1 TOX4 PAPOLA NFATC2 NAE1 NFYA ZNF638 SRRM2 ZNF281 HCFC1 KIFC1 | 3.95e-06 | 928 | 159 | 22 | int:XRCC6 |
| Interaction | CRTC1 interactions | 4.13e-06 | 31 | 159 | 5 | int:CRTC1 | |
| Interaction | CTBP1 interactions | TSHZ3 FOXK2 EP400 RBL2 NTRK1 MAML1 CREBBP CREB5 TUBG1 YEATS2 SEC24C NFATC2 SPOP SRRM2 | 4.31e-06 | 406 | 159 | 14 | int:CTBP1 |
| Interaction | KPNA1 interactions | PRPF31 HIF1A ZNF148 ING3 EP400 NTRK1 ADNP2 RUNX1T1 ARID2 SPOP NIPBL GABPA KPNA3 | 4.46e-06 | 351 | 159 | 13 | int:KPNA1 |
| Interaction | ASF1A interactions | ZNF384 HNF1B FOXK2 HIVEP1 EP400 EMSY YEATS2 ARID2 ZNF281 HCFC1 NPAT | 4.75e-06 | 249 | 159 | 11 | int:ASF1A |
| Interaction | TP63 interactions | KPNA4 DPH1 HIF1A FOXK2 RBL2 PIWIL1 ARHGEF12 PLEKHM1 YEATS2 SEC24C KRT6C NFYA | 5.53e-06 | 304 | 159 | 12 | int:TP63 |
| Interaction | CRX interactions | SP3 HNF1B FOXK2 ZNF148 EP400 MAML1 CREBBP KMT2C ARID2 NIPBL ZMYM4 | 5.74e-06 | 254 | 159 | 11 | int:CRX |
| Interaction | SP1 interactions | SP3 HIF1A ZNF148 SREBF1 SREBF2 CREB1 CREBBP MEF2C GTF2A1 NFYA TAF4 HCFC1 GABPA | 6.80e-06 | 365 | 159 | 13 | int:SP1 |
| Interaction | MED23 interactions | HMBOX1 HIF1A EP400 NTRK1 PPP1R12A SREBF1 CREBBP EMSY MED12L LTBP1 NIPBL | 8.89e-06 | 266 | 159 | 11 | int:MED23 |
| Interaction | ERCC3 interactions | 1.06e-05 | 175 | 159 | 9 | int:ERCC3 | |
| Interaction | MYB interactions | 1.07e-05 | 133 | 159 | 8 | int:MYB | |
| Interaction | SOX9 interactions | 1.18e-05 | 97 | 159 | 7 | int:SOX9 | |
| Interaction | KRT15 interactions | 1.22e-05 | 178 | 159 | 9 | int:KRT15 | |
| Interaction | EP300 interactions | DHX16 PRPF31 SP3 HNF1B TMEM201 HIF1A FOXK2 ZBTB33 ZNF148 PTBP2 SREBF1 SREBF2 MAML1 LAMP2 CREB1 CREBBP MEF2C SEC24C AP1G1 NFATC2 NFE2L2 NFYA SIK2 SRRM2 GCN1 GABPA KIFC1 | 1.36e-05 | 1401 | 159 | 27 | int:EP300 |
| Interaction | SRF interactions | 1.48e-05 | 139 | 159 | 8 | int:SRF | |
| Interaction | PHTF1 interactions | 1.64e-05 | 20 | 159 | 4 | int:PHTF1 | |
| Interaction | EFNA1 interactions | 1.75e-05 | 103 | 159 | 7 | int:EFNA1 | |
| Interaction | RBBP5 interactions | PRPF31 HNF1B FOXK2 CREBBP EMSY YEATS2 KMT2C ZNF532 TAF4 SRRM2 HCFC1 | 1.81e-05 | 287 | 159 | 11 | int:RBBP5 |
| Interaction | PHF21A interactions | TPR SP3 TSHZ3 HIVEP1 ZBTB33 RBM20 PHF21A YEATS2 TOX4 DST XRN1 NPAT | 1.85e-05 | 343 | 159 | 12 | int:PHF21A |
| Interaction | APEX1 interactions | DHX16 DPH1 PRPF31 ZNF384 HIF1A HIVEP1 ZNF148 EP400 NTRK1 PPP1R12A SREBF2 ZNF236 EMSY PAPOLA NFE2L2 ARID2 NAE1 PKD1 ZNF638 CKAP2L GATD1 ZNF281 NIPBL ZMYM4 KPNA3 | 2.11e-05 | 1271 | 159 | 25 | int:APEX1 |
| Interaction | ELF5 interactions | 2.22e-05 | 147 | 159 | 8 | int:ELF5 | |
| Interaction | CHD8 interactions | 2.32e-05 | 193 | 159 | 9 | int:CHD8 | |
| Interaction | MYOD1 interactions | 2.42e-05 | 194 | 159 | 9 | int:MYOD1 | |
| Interaction | MAFG interactions | 2.43e-05 | 44 | 159 | 5 | int:MAFG | |
| Interaction | SREBF2 interactions | EPHB2 TPR RBL2 SREBF1 SREBF2 CREB1 CREBBP NAE1 NFYA XRN1 NPAT | 2.48e-05 | 297 | 159 | 11 | int:SREBF2 |
| Interaction | EN1 interactions | 2.69e-05 | 110 | 159 | 7 | int:EN1 | |
| Interaction | KAT5 interactions | KPNA4 HMBOX1 TPR HIF1A ZBTB33 ING3 EP400 CREB1 CREBBP MAP3K1 IL4R KPNA3 | 2.82e-05 | 358 | 159 | 12 | int:KAT5 |
| Interaction | HDAC10 interactions | 3.03e-05 | 46 | 159 | 5 | int:HDAC10 | |
| Interaction | WWTR1 interactions | ZBTB33 EP400 PPP1R12A CREBBP EMSY YEATS2 TOX4 SMG7 ARID2 XRN1 ENG GCN1 HCFC1 | 3.14e-05 | 422 | 159 | 13 | int:WWTR1 |
| Interaction | FASN interactions | KPNA4 MON2 DPH1 HIF1A NTRK1 SREBF2 ZNF236 WNK1 EMSY WAC KMT2C PRDM10 SMG7 UBP1 ARID2 XRN1 CKAP2L LTBP1 SPOP TAF4 NIPBL ZMYM4 | 3.22e-05 | 1062 | 159 | 22 | int:FASN |
| Interaction | TBP interactions | HMBOX1 SP3 FOXK2 GTF2A1L CREBBP YEATS2 GTF2A1 NFE2L2 NFYA TAF4 | 3.38e-05 | 253 | 159 | 10 | int:TBP |
| Interaction | BAG2 interactions | DPH1 RC3H2 HIF1A ZNF143 NTRK1 PPP1R12A PIWIL1 WNK1 CREBBP HMCES TUBG1 PHC1 YEATS2 PAPOLA SIK2 SRRM2 | 3.44e-05 | 622 | 159 | 16 | int:BAG2 |
| Interaction | PARP1 interactions | DHX16 PRPF31 ZNF384 HNF1B HIF1A HIVEP1 ZNF148 EP400 NTRK1 SREBF2 CREBBP TUBG1 PHC1 RAD51AP1 SEC24C NFATC2 UBP1 NFYA PKNOX1 ZNF281 NIPBL ZMYM4 AQR KIFC1 KPNA3 | 3.75e-05 | 1316 | 159 | 25 | int:PARP1 |
| Interaction | KDM6A interactions | 4.45e-05 | 162 | 159 | 8 | int:KDM6A | |
| Interaction | ZNF131 interactions | 4.46e-05 | 119 | 159 | 7 | int:ZNF131 | |
| Interaction | LGR4 interactions | 4.54e-05 | 262 | 159 | 10 | int:LGR4 | |
| Interaction | CTNNB1 interactions | EPHB2 HMBOX1 HNF1B HIF1A ZBTB33 EP400 NTRK1 PPP1R12A CREB1 CREBBP TSC22D1 DST SEC24C PTPRJ PKD1 NFYA LRP6 SRRM2 RNF128 CDH9 EPHA8 | 4.63e-05 | 1009 | 159 | 21 | int:CTNNB1 |
| Interaction | ELK3 interactions | 4.70e-05 | 120 | 159 | 7 | int:ELK3 | |
| Interaction | SMG7 interactions | RC3H2 TSHZ3 HIVEP1 MAML1 TNRC6C CREBBP RBM20 YEATS2 SMG7 XRN1 AQR | 4.75e-05 | 319 | 159 | 11 | int:SMG7 |
| Interaction | ETS1 interactions | 4.96e-05 | 121 | 159 | 7 | int:ETS1 | |
| Interaction | POGZ interactions | 4.99e-05 | 265 | 159 | 10 | int:POGZ | |
| Interaction | STAT3 interactions | HIF1A HIVEP1 ZNF148 PDGFRB NTRK1 CREB1 CREBBP MAP3K1 CSF3R NFE2L2 NFYA ZNF281 MNDA | 5.54e-05 | 446 | 159 | 13 | int:STAT3 |
| Interaction | PAX7 interactions | 5.80e-05 | 124 | 159 | 7 | int:PAX7 | |
| Interaction | ZMYM2 interactions | SREBF2 ADNP2 CREB1 CREBBP PHF21A YEATS2 NFATC2 NXT1 GATD1 ZMYM4 | 6.02e-05 | 271 | 159 | 10 | int:ZMYM2 |
| Interaction | ZYX interactions | ZNF384 FOXK2 CCDC22 SREBF2 MLXIP WNK1 PHF21A FBXO10 SMG7 SEC24C PAPOLA | 6.27e-05 | 329 | 159 | 11 | int:ZYX |
| Interaction | ERG interactions | 7.16e-05 | 223 | 159 | 9 | int:ERG | |
| Interaction | TLX1 interactions | 7.67e-05 | 175 | 159 | 8 | int:TLX1 | |
| Interaction | KLF9 interactions | 9.50e-05 | 93 | 159 | 6 | int:KLF9 | |
| Interaction | SUMO1 interactions | 9.69e-05 | 287 | 159 | 10 | int:SUMO1 | |
| Cytoband | 12q13.13 | 9.40e-05 | 67 | 161 | 4 | 12q13.13 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.81e-06 | 14 | 121 | 4 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | 1.22e-05 | 160 | 121 | 8 | 555 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF384 SP3 TSHZ3 ZNF143 HIVEP1 ZBTB33 ZNF148 ZNF628 ADNP2 ZNF236 BNC1 PRDM10 ZNF773 ZNF532 ZNF620 ZNF281 | 2.38e-05 | 718 | 121 | 16 | 28 |
| GeneFamily | Keratins, type II | 2.97e-05 | 27 | 121 | 4 | 609 | |
| GeneFamily | HNF class homeoboxes | 1.33e-04 | 3 | 121 | 2 | 524 | |
| GeneFamily | Sterile alpha motif domain containing | 3.11e-04 | 88 | 121 | 5 | 760 | |
| GeneFamily | CD molecules|Mucins | 3.56e-04 | 21 | 121 | 3 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.04e-04 | 25 | 121 | 3 | 775 | |
| GeneFamily | ATAC complex | 3.30e-03 | 13 | 121 | 2 | 1058 | |
| GeneFamily | Basic leucine zipper proteins | 4.30e-03 | 49 | 121 | 3 | 506 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.41e-03 | 15 | 121 | 2 | 529 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.03e-03 | 394 | 121 | 8 | 471 | |
| GeneFamily | Armadillo repeat containing|Importins | 6.34e-03 | 18 | 121 | 2 | 596 | |
| GeneFamily | Basic helix-loop-helix proteins | 6.39e-03 | 110 | 121 | 4 | 420 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 SP3 HIF1A FOXK2 HIVEP1 ZNF148 PPP1R12A CREB1 CREBBP CREB5 PHF21A ITPR1 DST ZNF638 BICRAL SPOP TAF4 NIPBL ZMYM4 AQR EPHA4 NPAT KPNA3 | 2.97e-09 | 856 | 161 | 23 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 ZNF148 PPP1R12A MAML1 CREBBP DST NFE2L2 NFYA ZNF638 BICRAL SPOP DOP1A NPAT | 4.69e-08 | 300 | 161 | 13 | M8702 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HMBOX1 ZNF143 HIVEP1 SLC31A2 PTBP2 ADNP2 ATG14 CREBBP PLEKHM1 WAC TSC22D1 PRDM10 DST NFE2L2 PKD1 NFYA PKNOX1 LYPD3 NIPBL GABPA | 1.73e-07 | 822 | 161 | 20 | M6782 |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 9.39e-07 | 13 | 161 | 4 | MM743 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FOXK2 HIVEP1 ZNF148 PPP1R12A CREB1 CREBBP PHF21A DST ZNF638 SPOP TAF4 ZMYM4 EPHA4 KPNA3 | 1.21e-06 | 466 | 161 | 14 | M13522 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.86e-06 | 60 | 161 | 6 | M1401 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TPR DPH1 ZNF143 ZNF148 ING3 SLC31A2 CUBN BNC1 PAPOLA AP1G1 PKNOX1 HCFC1 EPHA4 KPNA3 | 4.23e-06 | 519 | 161 | 14 | M3395 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KPNA4 SELPLG TPR SP3 ZNF148 EP400 RBL2 PPP1R12A TNRC6C WNK1 CREB1 CREBBP WAC ITPR1 KMT2C PAPOLA PTPRJ NFATC2 ARID2 XCL2 XRN1 ZNF638 NIPBL GABPA NPAT | 4.68e-06 | 1492 | 161 | 25 | M40023 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | MON2 ZBTB33 ZNF148 PTBP2 RBL2 PPP1R12A LAMP2 CREB1 MEF2C WAC RAD51AP1 TSC22D1 PRDM10 PAPOLA NAE1 ENTPD1 SPOP TAF4 NIPBL IL4R ZMYM4 EPHB1 | 5.55e-06 | 1215 | 161 | 22 | M41122 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 6.94e-06 | 75 | 161 | 6 | MM605 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TPR DPH1 ZNF143 ZNF148 ING3 SLC31A2 CUBN BNC1 PAPOLA AP1G1 PKNOX1 HCFC1 EPHA4 KPNA3 | 7.08e-06 | 543 | 161 | 14 | MM997 |
| Coexpression | KRASNOSELSKAYA_ILF3_TARGETS_DN | 9.19e-06 | 46 | 161 | 5 | M12166 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 1.27e-05 | 174 | 161 | 8 | M6850 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.44e-05 | 177 | 161 | 8 | M39245 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 3.34e-05 | 199 | 161 | 8 | M3517 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 3.34e-05 | 199 | 161 | 8 | M5151 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 3.46e-05 | 200 | 161 | 8 | M330 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M9660 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP | 3.46e-05 | 200 | 161 | 8 | M8290 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M5087 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 3.46e-05 | 200 | 161 | 8 | M9133 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | DPH1 PTBP2 CREB5 ITPR1 NXT1 PKNOX1 BICRAL SRRM2 NIPBL ZMYM4 KPNA3 | 3.84e-05 | 399 | 161 | 11 | M41172 |
| Coexpression | BURTON_ADIPOGENESIS_12 | 4.31e-05 | 32 | 161 | 4 | M1558 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 4.31e-05 | 32 | 161 | 4 | MM668 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 4.80e-05 | 12 | 161 | 3 | M1769 | |
| Coexpression | BROWNE_HCMV_INFECTION_1HR_DN | 6.36e-05 | 218 | 161 | 8 | M9802 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | KPNA4 RC3H2 SP3 HIF1A ZBTB33 ING3 ATG2A TOX4 USF3 PAPOLA AP1G1 NFE2L2 PKD1 XRN1 LYPD3 ZNF281 | 6.76e-05 | 844 | 161 | 16 | M41129 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 7.46e-05 | 165 | 161 | 7 | M8121 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 8.43e-05 | 227 | 161 | 8 | M11234 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | STAB2 CUBN MEF2C PHF21A BNC1 GTF2A1 DST PTPRJ XCL2 ENG XCL1 CACNA2D3 | 9.42e-05 | 520 | 161 | 12 | MM1008 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.29e-04 | 180 | 161 | 7 | M8239 | |
| Coexpression | HAN_SATB1_TARGETS_DN | ZBTB33 EP400 TUBG2 RBL2 TSC22D1 DST PAPOLA AP1G1 ADGRF1 GCN1 | 1.51e-04 | 388 | 161 | 10 | M15491 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 1.91e-04 | 192 | 161 | 7 | M8272 | |
| Coexpression | GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP | 2.17e-04 | 196 | 161 | 7 | M3239 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.17e-04 | 196 | 161 | 7 | M4244 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | STAB2 CUBN MEF2C PHF21A BNC1 GTF2A1 DST PTPRJ ENG XCL1 CACNA2D3 | 2.19e-04 | 486 | 161 | 11 | M18517 |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP | 2.24e-04 | 197 | 161 | 7 | M7264 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 2.24e-04 | 197 | 161 | 7 | M4421 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | KPNA4 KRT6A ZNF143 ZNF148 SREBF1 BNC1 KMT2C TSC22D1 PRDM10 DST SMG7 ARID2 NXT1 ADGRF1 IL4R | 2.28e-04 | 843 | 161 | 15 | M2356 |
| Coexpression | GSE13229_MATURE_VS_INTMATURE_NKCELL_DN | 2.31e-04 | 198 | 161 | 7 | M3216 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 2.31e-04 | 198 | 161 | 7 | M4415 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN | 2.38e-04 | 199 | 161 | 7 | M3853 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 2.38e-04 | 199 | 161 | 7 | M7924 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 2.38e-04 | 199 | 161 | 7 | M3182 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 2.46e-04 | 200 | 161 | 7 | M9411 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.46e-04 | 200 | 161 | 7 | M9449 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.46e-04 | 200 | 161 | 7 | M291 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.46e-04 | 200 | 161 | 7 | M309 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 2.46e-04 | 200 | 161 | 7 | M4819 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN | 2.46e-04 | 200 | 161 | 7 | M8319 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN | 2.46e-04 | 200 | 161 | 7 | M9632 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 2.46e-04 | 200 | 161 | 7 | M9628 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN | 2.46e-04 | 200 | 161 | 7 | M3450 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 2.46e-04 | 200 | 161 | 7 | M9765 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 2.46e-04 | 200 | 161 | 7 | M7495 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 2.46e-04 | 200 | 161 | 7 | M6372 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 2.46e-04 | 200 | 161 | 7 | M6514 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_DN | 2.82e-04 | 145 | 161 | 6 | M0 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | KPNA4 HIVEP1 PTBP2 ADNP2 ATG14 HMCES EMSY PHC1 WAC AP1G1 NXT1 XCL1 KPNA3 | 3.07e-04 | 680 | 161 | 13 | M41089 |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 3.20e-04 | 96 | 161 | 5 | M5910 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 3.21e-04 | 209 | 161 | 7 | M16036 | |
| Coexpression | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER | 3.87e-04 | 100 | 161 | 5 | M14670 | |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 3.87e-04 | 100 | 161 | 5 | M14079 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_UP | 4.16e-04 | 156 | 161 | 6 | M17225 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_DN | 4.49e-04 | 58 | 161 | 4 | M13767 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2 | 4.74e-04 | 25 | 161 | 3 | MM511 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2 | 4.74e-04 | 25 | 161 | 3 | M15638 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 4.92e-04 | 161 | 161 | 6 | M6848 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | TPR SP3 PPP1R12A ARHGEF12 CREB1 CREBBP MAP3K1 GTF2A1 PRDM10 ARID2 GABPA NPAT | 4.24e-12 | 186 | 161 | 12 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.31e-09 | 193 | 161 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.11e-07 | 192 | 161 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-07 | 194 | 161 | 8 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-07 | 194 | 161 | 8 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.97e-07 | 196 | 161 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 199 | 161 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-07 | 200 | 161 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.38e-06 | 165 | 161 | 7 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 173 | 161 | 7 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 173 | 161 | 7 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-06 | 176 | 161 | 7 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-06 | 180 | 161 | 7 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-06 | 182 | 161 | 7 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-06 | 184 | 161 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 188 | 161 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 188 | 161 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-06 | 192 | 161 | 7 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-06 | 192 | 161 | 7 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.69e-06 | 193 | 161 | 7 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.69e-06 | 193 | 161 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.92e-06 | 194 | 161 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 194 | 161 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 7.16e-06 | 195 | 161 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.40e-06 | 196 | 161 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.65e-06 | 197 | 161 | 7 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.65e-06 | 197 | 161 | 7 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.91e-06 | 198 | 161 | 7 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 198 | 161 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 198 | 161 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 7.91e-06 | 198 | 161 | 7 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 7.91e-06 | 198 | 161 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.17e-06 | 199 | 161 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.45e-06 | 200 | 161 | 7 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.45e-06 | 200 | 161 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.02e-05 | 136 | 161 | 6 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 150 | 161 | 6 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|tumor_Lung / Location, Cell class and cell subclass | 2.23e-05 | 156 | 161 | 6 | b5851474ba14dd2b4867415828b52dd98ecdd6d3 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|normal_Lung / Location, Cell class and cell subclass | 2.48e-05 | 159 | 161 | 6 | f95a5570bf153fc5c598aba855db6b47ba818463 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.66e-05 | 161 | 161 | 6 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | Influenza_Severe-B_memory|World / Disease group and Cell class | 2.76e-05 | 162 | 161 | 6 | 21eb96cd4fecd85dd6acbbc3760944fa1a7cff42 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 3.06e-05 | 165 | 161 | 6 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-05 | 166 | 161 | 6 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.50e-05 | 169 | 161 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 170 | 161 | 6 | 3e52d40b0c36ab5b627a2dad025248901af8a320 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-05 | 171 | 161 | 6 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-05 | 171 | 161 | 6 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 3.74e-05 | 171 | 161 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | severe_influenza-B_memory|World / disease group, cell group and cell class (v2) | 3.86e-05 | 172 | 161 | 6 | 0ff38f9431cec73250c580a6010cb7891a3fe3f1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 172 | 161 | 6 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 172 | 161 | 6 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 175 | 161 | 6 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 4.25e-05 | 175 | 161 | 6 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 178 | 161 | 6 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-05 | 179 | 161 | 6 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 180 | 161 | 6 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 5.13e-05 | 181 | 161 | 6 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.45e-05 | 183 | 161 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.45e-05 | 183 | 161 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-05 | 183 | 161 | 6 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.62e-05 | 184 | 161 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | 9ce3bd121869215a4e6114a310f9d2fb5adaef61 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 186 | 161 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | a7fd35eabcfb534019dfe5a8a600bf2ec47c1ac2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.96e-05 | 186 | 161 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | 18c40203463d4dd8558c04977d52e400a8268f90 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.96e-05 | 186 | 161 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 187 | 161 | 6 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 187 | 161 | 6 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 187 | 161 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 187 | 161 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.14e-05 | 187 | 161 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 188 | 161 | 6 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.33e-05 | 188 | 161 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.52e-05 | 189 | 161 | 6 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.52e-05 | 189 | 161 | 6 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | mild-Others|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.71e-05 | 190 | 161 | 6 | 782dc1b612ac1faad7cc2781bfda92a079830d38 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 190 | 161 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 190 | 161 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 191 | 161 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 191 | 161 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 191 | 161 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 191 | 161 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 191 | 161 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-05 | 193 | 161 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-05 | 193 | 161 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-05 | 193 | 161 | 6 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| Computational | RTK signaling. | 8.27e-06 | 46 | 114 | 6 | MODULE_259 | |
| Computational | Genes in the cancer module 85. | 1.52e-05 | 51 | 114 | 6 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 2.91e-05 | 57 | 114 | 6 | MODULE_199 | |
| Computational | Genes in the cancer module 51. | 3.56e-05 | 36 | 114 | 5 | MODULE_51 | |
| Computational | Genes in the cancer module 200. | 1.74e-04 | 27 | 114 | 4 | MODULE_200 | |
| Computational | Genes in the cancer module 80. | 3.43e-04 | 32 | 114 | 4 | MODULE_80 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZNF143 FOXK2 PPP1R12A ADNP2 CREBBP PHF21A WAC NFE2L2 NFYA TAF4 NIPBL EPHA4 | 6.52e-09 | 182 | 160 | 12 | 3887_DN |
| Drug | Sp 1 (pharmaceutical) | KPNA4 SP3 HIF1A ZBTB33 ZNF148 RBL2 MAML1 RUNX1T1 CREB1 PHF21A MAP3K1 GTF2A1 BRDT UBP1 TAF4 MUC4 HCFC1 | 3.42e-07 | 548 | 160 | 17 | CID000099040 |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | KPNA4 ZNF143 HIVEP1 ADNP2 ATG2A PAPOLA NFYA ZNF281 NIPBL HCFC1 | 4.45e-07 | 174 | 160 | 10 | 1302_UP |
| Drug | TiNi | 5.37e-07 | 100 | 160 | 8 | CID000159408 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.48e-07 | 178 | 160 | 10 | 3998_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 1.10e-06 | 192 | 160 | 10 | 5206_DN | |
| Drug | AC1L9MJT | 1.10e-06 | 192 | 160 | 10 | CID000448959 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 3.19e-06 | 169 | 160 | 9 | 2193_UP | |
| Drug | CNS 1145 | 3.26e-06 | 33 | 160 | 5 | CID000190902 | |
| Drug | IHC-64 | 3.26e-06 | 33 | 160 | 5 | CID000162753 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.11e-06 | 179 | 160 | 9 | 5822_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.34e-06 | 180 | 160 | 9 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.39e-06 | 184 | 160 | 9 | 2321_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.68e-06 | 185 | 160 | 9 | 1673_DN | |
| Drug | SC-791 | 6.71e-06 | 6 | 160 | 3 | CID010291510 | |
| Drug | ponatinib | 8.37e-06 | 68 | 160 | 6 | ctd:C545373 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.01e-06 | 192 | 160 | 9 | 6435_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.79e-06 | 194 | 160 | 9 | 4134_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.79e-06 | 194 | 160 | 9 | 4309_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A | 1.02e-05 | 195 | 160 | 9 | 1336_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 4539_DN | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 6488_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 200 | 160 | 9 | 6278_DN | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.00e-05 | 79 | 160 | 6 | CID005287890 | |
| Drug | mant-GTP | 2.64e-05 | 50 | 160 | 5 | CID000128647 | |
| Drug | VX-745 | 2.65e-05 | 25 | 160 | 4 | CID003038525 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.29e-05 | 174 | 160 | 8 | 7530_DN | |
| Drug | 1-2q | CACNA1A PRPF31 KRT6A KRT6B HNF1B KRT6C KRT77 MAP3K21 ENG IL4R | 3.97e-05 | 289 | 160 | 10 | CID000011820 |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.36e-05 | 181 | 160 | 8 | 5743_DN | |
| Drug | Cinildipine | 4.60e-05 | 56 | 160 | 5 | CID000002752 | |
| Drug | Dichlorodiphenyldichloroethane | 4.86e-05 | 29 | 160 | 4 | ctd:D003632 | |
| Drug | bis-amidinium derivative of hoechst 33258 | 5.05e-05 | 93 | 160 | 6 | CID000449422 | |
| Drug | Glucose | HIF1A FOXK2 PTBP2 NTRK1 PPP1R12A SREBF1 SREBF2 MAML1 SLC34A2 LAMP2 CREB1 CREBBP MAP3K1 GTF2A1 TSC22D1 TENM4 NFE2L2 UBP1 ARID2 MED12L LTBP1 NIPBL DOP1A KPNA3 | 5.64e-05 | 1420 | 160 | 24 | ctd:D005947 |
| Drug | testosterone enanthate | TPR HIF1A ZNF148 RBL2 PPP1R12A ADNP2 WNK1 CREB1 YEATS2 TOX4 ENTPD1 LTBP1 SRRM2 ENG | 5.77e-05 | 575 | 160 | 14 | ctd:C004648 |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 5.92e-05 | 189 | 160 | 8 | 7074_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 5.92e-05 | 189 | 160 | 8 | 1288_DN | |
| Drug | 2-Formyl-Protoporphryn Ix | 6.37e-05 | 31 | 160 | 4 | CID011963946 | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.37e-05 | 191 | 160 | 8 | 4811_DN | |
| Drug | nilvadipine | 6.44e-05 | 60 | 160 | 5 | CID000004494 | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 1236_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 6730_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 6.86e-05 | 193 | 160 | 8 | 1982_DN | |
| Drug | IAA-94 | 6.97e-05 | 61 | 160 | 5 | CID000003667 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 7.11e-05 | 194 | 160 | 8 | 1209_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 7.11e-05 | 194 | 160 | 8 | 4524_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 2805_UP | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 4355_UP | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 2064_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 4781_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 6159_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 5860_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 1821_DN | |
| Drug | wortmannin; Down 200; 0.01uM; SKMEL5; HG-U133A | 7.64e-05 | 196 | 160 | 8 | 506_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 3729_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 5886_DN | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 5851_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 2766_UP | |
| Drug | lercanidipine | 8.14e-05 | 63 | 160 | 5 | CID000065866 | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 7279_UP | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 4947_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 2246_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6208_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HG-U133A | 8.20e-05 | 198 | 160 | 8 | 1887_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 6476_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; PC3; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 6702_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 5068_DN | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 5862_DN | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; HL60; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 2939_DN | |
| Drug | Catechin | TPR SP3 TMEM201 HIF1A HIVEP1 ING3 PPP1R12A SREBF1 ADNP2 TNRC6C MLXIP CREB1 USF3 NFE2L2 MAP3K21 ENG HCFC1 DOP1A | 9.65e-05 | 928 | 160 | 18 | ctd:D002392 |
| Drug | BIRB796 | 1.02e-04 | 66 | 160 | 5 | CID000156422 | |
| Drug | gallopamil | 1.09e-04 | 67 | 160 | 5 | CID000001234 | |
| Drug | A25618 | SP3 KRT6B HIF1A ZBTB33 ZNF148 PDGFRB NTRK1 CREB1 CREBBP MEF2C CREB5 PHF21A TSC22D1 BRDT PKNOX1 MUC4 | 1.22e-04 | 777 | 160 | 16 | CID000005562 |
| Drug | phorbol acetate myristate | CACNA1A KRT6A KRT6B HIF1A PDGFRB MAML1 CREB1 CREBBP CREB5 MAP3K1 RYR2 ITPR1 TSC22D1 DST KRT6C PTPRJ NFATC2 KRT77 PKD1 MUC4 MNDA IL4R CACNA2D3 | 1.24e-04 | 1399 | 160 | 23 | CID000004792 |
| Drug | AC1L2AC7 | 1.26e-04 | 69 | 160 | 5 | CID000068733 | |
| Drug | L 709049 | 1.46e-04 | 15 | 160 | 3 | ctd:C096429 | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 162 | 160 | 7 | 7340_UP | |
| Drug | CAS 298-57-7 | 1.64e-04 | 73 | 160 | 5 | CID000002761 | |
| Drug | Phe-gly | 1.64e-04 | 73 | 160 | 5 | CID000098207 | |
| Drug | Losartan | 1.70e-04 | 165 | 160 | 7 | ctd:D019808 | |
| Drug | ethosuximide | 1.75e-04 | 74 | 160 | 5 | CID000003291 | |
| Drug | Clorgyline | 1.90e-04 | 168 | 160 | 7 | ctd:D003010 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1A TPR PDGFRB RBL2 NTRK1 PPP1R12A BLNK RYR2 ITPR1 ENTPD1 PKD1 ENG CACNA2D3 | 1.96e-04 | 568 | 160 | 13 | CID000000806 |
| Drug | clobestasol propionate | 2.15e-04 | 17 | 160 | 3 | CID000002791 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.20e-04 | 172 | 160 | 7 | 7073_DN | |
| Drug | tetrathiomolybdate | 2.25e-04 | 78 | 160 | 5 | ctd:C020809 | |
| Drug | nisoldipine | 2.25e-04 | 78 | 160 | 5 | CID000004499 | |
| Drug | Arsenates | 2.26e-04 | 122 | 160 | 6 | ctd:D001149 | |
| Drug | Nicotine | TPR KRT6B HIF1A PDGFRB PTBP2 RBL2 SREBF1 RUNX1T1 CREB1 MEF2C PHF21A RYR2 KMT2C TSC22D1 NFATC2 ENG IL4R IGSF3 | 2.43e-04 | 1000 | 160 | 18 | ctd:D009538 |
| Drug | Simvastatin | HIF1A PDGFRB NTRK1 PPP1R12A SREBF1 SREBF2 CREB1 RYR2 NFE2L2 ENTPD1 LRP6 IL4R EPHA8 | 2.44e-04 | 581 | 160 | 13 | ctd:D019821 |
| Drug | 2,6-dihydroxybenzoic acid | 2.44e-04 | 175 | 160 | 7 | CID000009338 | |
| Drug | papaverine | 2.53e-04 | 176 | 160 | 7 | CID000004680 | |
| Drug | dithranol | 2.57e-04 | 18 | 160 | 3 | CID000002202 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.71e-04 | 178 | 160 | 7 | 4436_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.80e-04 | 179 | 160 | 7 | 4585_DN | |
| Drug | Dichlorodiphenyl Dichloroethylene | CACNA1A PDGFRB NTRK1 SREBF1 CREB1 CREBBP NFE2L2 CACNA2D3 EPHA8 | 2.96e-04 | 302 | 160 | 9 | ctd:D003633 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.10e-04 | 182 | 160 | 7 | 5802_DN | |
| Drug | Ebna | 3.21e-04 | 183 | 160 | 7 | CID000018835 | |
| Drug | Olux | 3.56e-04 | 20 | 160 | 3 | CID000032797 | |
| Drug | N1-acetylspermidine | 3.56e-04 | 20 | 160 | 3 | CID000000496 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.65e-04 | 187 | 160 | 7 | 6671_DN | |
| Disease | body weight | HNF1B ZNF143 HIVEP1 GTF2A1L TUBG2 ARHGEF12 RUNX1T1 RFX3 HMCES PHF21A ITPR1 TOX4 USF3 PTPRJ NFATC2 PKD1 ZNF638 LTBP1 NIPBL CDH9 EPHA4 EPHB1 | 1.23e-06 | 1261 | 159 | 22 | EFO_0004338 |
| Disease | endometrial neoplasm | 2.45e-05 | 11 | 159 | 3 | EFO_0004230 | |
| Disease | lipid storage disease (biomarker_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:9455 (biomarker_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | EPHB2 HNF1B HIF1A STAB2 CREBBP MAP3K1 WAC ITPR1 KMT2C NFE2L2 ARID2 SPOP MUC4 | 3.15e-05 | 616 | 159 | 13 | C0376358 |
| Disease | Huntington's disease (biomarker_via_orthology) | 8.17e-05 | 16 | 159 | 3 | DOID:12858 (biomarker_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 1.02e-04 | 45 | 159 | 4 | C0278701 | |
| Disease | Prostatic Neoplasms | HNF1B HIF1A STAB2 CREBBP MAP3K1 WAC ITPR1 KMT2C NFE2L2 ARID2 SPOP MUC4 | 1.36e-04 | 616 | 159 | 12 | C0033578 |
| Disease | Neurodevelopmental Disorders | 1.51e-04 | 93 | 159 | 5 | C1535926 | |
| Disease | lymphotactin measurement | 1.72e-04 | 4 | 159 | 2 | EFO_0008214 | |
| Disease | Pachyonychia congenita syndrome | 1.72e-04 | 4 | 159 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.72e-04 | 4 | 159 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.72e-04 | 4 | 159 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.72e-04 | 4 | 159 | 2 | C1721007 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 1.72e-04 | 4 | 159 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | pre-eclampsia (is_marker_for) | 2.75e-04 | 58 | 159 | 4 | DOID:10591 (is_marker_for) | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 2.85e-04 | 5 | 159 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita | 2.85e-04 | 5 | 159 | 2 | C0265334 | |
| Disease | post-operative stroke, response to surgery | 2.85e-04 | 5 | 159 | 2 | EFO_0009951, EFO_0009956 | |
| Disease | cortical thickness | MON2 ANKRD13B PTBP2 SREBF1 ARHGEF12 RUNX1T1 BBS9 MEF2C PLEKHM1 MAP3K1 ITIH5 BNC1 SMG7 PKD1 CACNA2D3 EPHA4 | 3.54e-04 | 1113 | 159 | 16 | EFO_0004840 |
| Disease | heart conduction disease (implicated_via_orthology) | 6.79e-04 | 32 | 159 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.81e-04 | 195 | 159 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | survival time | 1.01e-03 | 9 | 159 | 2 | EFO_0000714 | |
| Disease | complement C1q subcomponent subunit C measurement | 1.26e-03 | 10 | 159 | 2 | EFO_0801492 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 1.26e-03 | 10 | 159 | 2 | cv:CN043592 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.43e-03 | 152 | 159 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Ductal Carcinoma | 1.54e-03 | 11 | 159 | 2 | C1176475 | |
| Disease | hypertrophic cardiomyopathy | 1.57e-03 | 92 | 159 | 4 | EFO_0000538 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.65e-03 | 157 | 159 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.77e-03 | 95 | 159 | 4 | C0279626 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.84e-03 | 12 | 159 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 1.85e-03 | 45 | 159 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | salicylurate measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0010532 | |
| Disease | pancreatic cancer (is_marker_for) | 2.21e-03 | 101 | 159 | 4 | DOID:1793 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.36e-03 | 49 | 159 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Tourette syndrome | 2.50e-03 | 50 | 159 | 3 | EFO_0004895 | |
| Disease | triacylglycerol 48:4 measurement | 2.52e-03 | 14 | 159 | 2 | EFO_0010407 | |
| Disease | cortical surface area measurement | MON2 DHX16 CACNA1A SREBF1 ARHGEF12 RUNX1T1 BBS9 MEF2C PLEKHM1 PHF21A MAP3K1 ITIH5 PKD1 XRN1 EPHA4 EPHB1 | 2.55e-03 | 1345 | 159 | 16 | EFO_0010736 |
| Disease | Down syndrome (implicated_via_orthology) | 2.89e-03 | 15 | 159 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | tumor necrosis factor beta measurement | 2.89e-03 | 15 | 159 | 2 | EFO_0008308 | |
| Disease | Intellectual Disability | 3.03e-03 | 447 | 159 | 8 | C3714756 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.23e-03 | 355 | 159 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | response to methotrexate | 3.29e-03 | 16 | 159 | 2 | GO_0031427 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 3.29e-03 | 16 | 159 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 3.41e-03 | 268 | 159 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 3.72e-03 | 17 | 159 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 3.72e-03 | 17 | 159 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | forced expiratory volume | TSHZ3 ZNF628 BBS9 RBM20 PLEKHM1 MAP3K1 RYR2 DST SEC24C CACNA2D3 KPNA3 | 3.78e-03 | 789 | 159 | 11 | EFO_0004314 |
| Disease | urate measurement, spine bone mineral density | 3.81e-03 | 58 | 159 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.00e-03 | 59 | 159 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TSHZ3 HIVEP1 BLNK RUNX1T1 PHF21A RYR2 BNC1 TENM4 BICRAL CACNA2D3 EPHB1 | 4.22e-03 | 801 | 159 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | gout | 4.28e-03 | 196 | 159 | 5 | EFO_0004274 | |
| Disease | diet measurement | HNF1B PTBP2 RUNX1T1 RFX3 MEF2C PLEKHM1 ITPR1 TENM4 DST ARID2 SIK2 NIPBL EPHA4 | 4.58e-03 | 1049 | 159 | 13 | EFO_0008111 |
| Disease | superior temporal gyrus volume measurement | 4.65e-03 | 19 | 159 | 2 | EFO_0010331 | |
| Disease | fish consumption measurement | 5.03e-03 | 64 | 159 | 3 | EFO_0010139 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.03e-03 | 64 | 159 | 3 | DOID:4947 (is_marker_for) | |
| Disease | urinary microalbumin measurement | 5.14e-03 | 20 | 159 | 2 | EFO_0010967 | |
| Disease | Adenocarcinoma of prostate | 5.14e-03 | 20 | 159 | 2 | C0007112 | |
| Disease | monocyte count | HIVEP1 STAB2 PDGFRB PPP1R12A ARHGEF12 WNK1 MEF2C CREB5 PLEKHM1 CSF3R PTPRH PKD1 MED12L ENG NPAT | 5.26e-03 | 1320 | 159 | 15 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENSLIVTNPSGTQTN | 1141 | O00555 | |
| IQVTSPLSQQVQTQS | 121 | Q96L91 | |
| TTTSQVQVPQIQGQA | 2786 | Q96L91 | |
| VQQQTPVASIQQVAS | 3051 | Q96L91 | |
| PVASIQQVASASQQA | 3056 | Q96L91 | |
| QQVASASQQASPQTV | 3061 | Q96L91 | |
| ASQQASPQTVALTQA | 3066 | Q96L91 | |
| IPSQSVEVSQSQSTQ | 446 | Q6ZNE5 | |
| ISPLNVVQGASVNSS | 186 | Q58F21 | |
| QNPSTTVGNLASVVS | 336 | Q5T601 | |
| TVAQSSQPTRVANNS | 761 | Q9UK96 | |
| QDVAFTQQASQTSVI | 806 | Q01954 | |
| IEQVQTQTHVASAPA | 486 | Q68CP9 | |
| IVSATSVQNFQVATG | 861 | Q68CP9 | |
| QTQSTPTVQAAAQAQ | 911 | Q92793 | |
| PIAFVNAISTTSVNN | 1396 | Q5JWR5 | |
| VAPTVSQINAEFVTQ | 11 | O60306 | |
| QAQATQVSDVPATSR | 306 | O60826 | |
| PTSTQAQQKESIQAV | 381 | O60231 | |
| VSTIQFVSTLQAAAQ | 181 | Q9BZG8 | |
| EQSAQPNASQATTRT | 146 | Q6NXP0 | |
| QQSFVQVRVSPSVSE | 471 | P17813 | |
| VVVTVNPQSSSTQWE | 736 | Q2TAZ0 | |
| VSSSAVVPVNQGVNS | 526 | Q6IQ32 | |
| TASQGPQTDSVIQNS | 1286 | Q9NZN5 | |
| NNTVTTTAGNVISVI | 466 | Q9HBD1 | |
| PTVTTNVQNSQDKSI | 111 | Q96B01 | |
| AQTAVTNNTAAATVL | 106 | Q5T481 | |
| SVSQSNVVVLPGNSA | 881 | Q14207 | |
| ATATVTANNGQTVTI | 731 | Q08999 | |
| TNPSVTVITIQASNS | 726 | O43747 | |
| ITQTLSQANPTAITA | 326 | Q86YJ7 | |
| PDNTSSLTQAQVASV | 261 | Q8N0Y5 | |
| QQVIQHNTITTSSSV | 471 | Q02930 | |
| QHVSVNITTNQAAPS | 421 | P54762 | |
| SQVINPTAITVSAAQ | 921 | P51610 | |
| IPRQTNVGQNTSVSA | 781 | Q92585 | |
| TSTPNISQTNQIQTE | 5466 | Q8WXI7 | |
| ISQTNQIQTEPTASL | 5471 | Q8WXI7 | |
| QAPQTTQESQTTRSV | 641 | Q99102 | |
| PTVIQQQNATSQRAA | 861 | Q13469 | |
| PASQVTSIGQQVAES | 306 | O60320 | |
| VSVQVNVSFPASVQL | 276 | P04629 | |
| PSNVSNIDVSTNTTA | 626 | Q12913 | |
| NIASGTSAQTQAVVQ | 141 | O00505 | |
| TSAQTQAVVQSNAVP | 146 | O00505 | |
| VGQVNVSVVQSTISS | 481 | P48668 | |
| PQQNIVSCVSVSTQT | 201 | Q8NEZ4 | |
| QQTSQQQAGSVVLSP | 1951 | Q86YW9 | |
| SANANVTVTIQGSIA | 791 | Q86UX2 | |
| ETLPSNNTVAQVQSN | 206 | Q86T24 | |
| TPVNQATLSQTQGSE | 251 | Q86T24 | |
| DQSTTLQTRQPVFVQ | 1506 | Q14643 | |
| VGQVNISVVQSTVSS | 481 | P02538 | |
| QAQQQGDTPAVSSSV | 556 | Q06455 | |
| TASRIIQTAQTTPVQ | 541 | Q01167 | |
| TSVSSQAAQAASPQV | 7421 | Q03001 | |
| QPVTAVALATASLQT | 436 | Q06546 | |
| QSTVTVFQQTQIQEP | 596 | Q16665 | |
| VFQQTQIQEPTANAT | 601 | Q16665 | |
| FVSQNITPVNESVVS | 1631 | Q5HYC2 | |
| LNVTVGTPAVQSSNQ | 296 | Q53TS8 | |
| PDQSVSVTVTTNQAA | 426 | P54764 | |
| VVQTSGSQESAVQNI | 4551 | Q5CZC0 | |
| SLTTVPQTQGQTTAQ | 71 | Q9BW19 | |
| ISQAVVAQVTGISQS | 186 | Q6NT76 | |
| SPQFASVNITTNQAA | 421 | P29323 | |
| SVNITTNQAAPSAVS | 426 | P29323 | |
| SQQTTVVPESDSNSQ | 336 | Q9NXR8 | |
| VGQVNISVVQSTVSS | 481 | P04259 | |
| SASQVIAPTQVTEIN | 861 | Q14766 | |
| FIATNQAQSPETSVA | 156 | Q16236 | |
| TSVAAKQPQTSVVQN | 441 | Q6KC79 | |
| TDVQNTPVNLQTSSK | 171 | Q96BD5 | |
| TVVVSSVPSQNLEIQ | 1001 | O75581 | |
| VLVQAFVQNGTVSTN | 171 | P13473 | |
| QSAQSLATPVVSVAT | 286 | Q06413 | |
| QTVEKAASQSTQVPT | 471 | Q92616 | |
| AALSTPSQQVQESVA | 1346 | Q92616 | |
| VVQVASATSPHQSQQ | 946 | Q9NQV6 | |
| TNNTAAATVRQVVTV | 161 | Q7Z3U7 | |
| GASTQVTFVPQNQTI | 216 | P49961 | |
| LNVSVVVSPNFDSVS | 411 | Q3SYG4 | |
| NVTLTAANVTVSLPV | 176 | O95274 | |
| PAVTAASVTNIQATE | 561 | P51003 | |
| ASVTNIQATEVSVPQ | 566 | P51003 | |
| ASTVSQSNVVIAPAA | 601 | Q9HAP2 | |
| KNSSVVNPTLVATTQ | 96 | Q8TAX7 | |
| TIQSGSNQLVVTFNS | 2771 | O60494 | |
| VITPSNTFTAVFQSQ | 2891 | O60494 | |
| LVTGQNASSTVPAVQ | 196 | Q8NB37 | |
| ASLQVDTVVPNATVS | 951 | O75054 | |
| NAQSSSQTPKIVNFV | 801 | P24394 | |
| LKTTPVASQQNASSV | 256 | Q8WV28 | |
| QQNTRKPVTSQAVSS | 366 | Q6AI39 | |
| QTQPSQLISGQVASE | 426 | Q6AI39 | |
| PVNKSNVVTASTSIQ | 791 | Q8IZS8 | |
| STRNISPTINQANIV | 936 | Q8TD84 | |
| VNLPTSISQQTIAET | 56 | O15432 | |
| VNITTNQAAPSQVVV | 431 | P29322 | |
| TVQAQPQIATLAQVS | 26 | P16220 | |
| SVIQSPQVQTVQIST | 76 | P16220 | |
| VSTQPQSQSGTSDQV | 736 | Q99062 | |
| AASPSQTVQRAVSVN | 411 | P01854 | |
| SSQSSQDSQPVVHVI | 726 | Q7Z589 | |
| QHVAQSQTATQTSVV | 871 | Q7Z589 | |
| SVQQGVVQSLFSVSS | 996 | P53992 | |
| QTGNNTTVNIIISTV | 3861 | Q92736 | |
| TTTVNITLTDVNNNP | 251 | Q9ULB4 | |
| AVSSVVNNSRNNTPE | 251 | Q96FZ2 | |
| GSNSQAVVTQEPSLT | 16 | A0A075B6I9 | |
| VSSINVSVNAVQTVV | 211 | P09619 | |
| ANSANSVVVQPQASV | 2891 | P98161 | |
| TAVQLQTEAQVASAS | 31 | P23511 | |
| VASASGQQVQTLQVV | 41 | P23511 | |
| QNFILTAQASPSNTV | 111 | Q9UKK6 | |
| TSFTPNQETQAQRQV | 186 | P41218 | |
| QSLNTSQAQSVPVIN | 446 | P35680 | |
| SQAQSVPVINSVAGS | 451 | P35680 | |
| SPSSLRAAQQQTVQQ | 511 | Q13233 | |
| QETAQLVGSTASQQP | 16 | Q96J94 | |
| AQVNSVPTNGLSQET | 316 | Q9Y4G2 | |
| QVSQAQTTVQPSATL | 526 | O00268 | |
| IQTTQPAATEAQTTQ | 121 | Q14242 | |
| AQTTQPTGLEAQTTA | 181 | Q14242 | |
| TGEQIQTISVQSTFQ | 226 | Q6IMI4 | |
| PSVNSQAQETTIIAS | 21 | Q8NFQ8 | |
| DRNNPVIQSSTTTNT | 746 | Q9HCJ0 | |
| RQGSITSPQANEQSV | 851 | Q9UQ35 | |
| QAVTAVQTANTPLSG | 151 | Q9UKA9 | |
| PQTAVSQLAQTACVV | 961 | Q5TCX8 | |
| VQSQQIQSAITGTIS | 171 | P55347 | |
| LQTSVASQAAVPTQV | 16 | P48380 | |
| PTAQSTSQLQVQALT | 751 | Q92540 | |
| VSLQVPVSNEISNSA | 336 | Q8TEB7 | |
| VSQQQESVSTLPASV | 651 | Q9H0K1 | |
| VPENTTSATNTTVNN | 291 | Q86UG4 | |
| TPAASTENTTQILAN | 196 | Q99935 | |
| SQSATQQPVTADKQQ | 491 | Q9BTA9 | |
| GSVSSQQQQPTVNTS | 391 | Q15714 | |
| TAAPVTTTVTSQIQQ | 221 | P36956 | |
| ADVTTVNGTQTNPNI | 441 | Q8IYA6 | |
| FTNKTQINVTVPSTA | 306 | O95436 | |
| QTQQVLIPASQQATA | 101 | P52655 | |
| QTKPTGTQQSTNTAV | 96 | P47992 | |
| QTKPTGTQQSTNTAV | 96 | Q9UBD3 | |
| ASAQQVKTTQTSNAP | 286 | A0JNW5 | |
| QQQTVVVPASSLANA | 501 | Q9HCE3 | |
| LTPHSQASVTQNITV | 76 | Q8TF68 | |
| VATVTQSGLSQQVTL | 486 | P52747 | |
| QNPSFSQINQLVSTI | 221 | P23258 | |
| GVVFSPQVSQTNSNV | 246 | Q9UNN4 | |
| PQVSQTNSNVESVLS | 251 | Q9UNN4 | |
| QPILTVQQQTQATAF | 1761 | P12270 | |
| VSVVQDSVNISGQNT | 161 | O43791 | |
| TQAQNIQVSTAQPVV | 381 | Q02447 | |
| QSLVTSSQVQPVTIQ | 186 | Q12772 | |
| NISVSTQLTTNQTNP | 176 | Q6ZNG0 | |
| VVSVTASTTQGQQLS | 166 | Q8WWY3 | |
| KEAQSSQATPVQTSQ | 1621 | Q8IZH2 | |
| VQTSQPDSSNIVKVS | 1631 | Q8IZH2 | |
| VSQQSVIQSAGVSVL | 561 | Q9Y2X9 | |
| NVTVSQINTVLNGRT | 2646 | Q6N022 | |
| TSNLTVLVPSQQATE | 1026 | Q8WWQ8 | |
| PAAQTVTVSQGSQTE | 316 | P78364 | |
| AVLPSVSVSQANSVS | 846 | Q68DE3 | |
| AQNFSSAVKSPVQVI | 201 | Q5SNT2 | |
| TEQINSQIAQTKSPS | 1011 | Q63HK5 | |
| QSASVEVPSSNVQQH | 101 | Q6PK81 | |
| ASQTSGEQIQPSATI | 356 | Q9NZI7 | |
| SSQPSSQAVSDVIQQ | 346 | Q9UL36 | |
| QNPSFSQINQLVSTI | 221 | Q9NRH3 | |
| SQPSVTQAAVASVID | 496 | Q9UQR1 | |
| SQQAVLESTQGVSQV | 1031 | Q9H4A3 | |
| VAVAQTQATQPTTLA | 1051 | Q9H4A3 | |
| TVGATVNSQAAQAQP | 2221 | Q9H4A3 | |
| NVNTALNTTQIPSSI | 271 | Q13564 | |
| RQNVSISTVPNAVTS | 466 | Q9HD43 | |
| TQPKQTSVASANQVS | 2581 | P15822 | |
| EPIKSVNQSINQTVS | 306 | Q14966 | |
| STATIQPSQQAQIVT | 406 | O94842 | |
| TVNSNSVLQGAVPTV | 901 | Q5VZL5 | |
| AQPVQTLTKAQVTAA | 711 | Q9ULM3 | |
| TTVQLQPAQEVTTVQ | 841 | Q5EBL2 | |
| NIASGTSEQTQAVVQ | 141 | O00629 | |
| TSEQTQAVVQSNAVP | 146 | O00629 | |
| LQSHVSISVQNSQVS | 481 | Q7Z794 | |
| ATNSTTAALIVNNAV | 511 | Q5VV43 | |
| TNANTSSTQAAPVAV | 381 | O14974 |